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Abstract 
Validations of research methods for urinary incontinence.  
Scored questionnaires in clinical practice and epidemiological research. 
Atle Klovning (Dissertation for the degree of philosophiae doctor, PhD). 
Many clinicians and researchers have claimed that too many questionnaires for diagnosing 
and assessing urinary incontinence have been developed, and that the time has come for 
recommending a subset of validated scored questionnaires to be used in clinical practice and 
research. Our research group has over the past 25 years applied different strategies for 
validating scored questionnaires to be used in clinical practice and epidemiological research 
on urinary incontinence (UI). 
This PhD-thesis is based on the findings in two studies: one clinical, diagnostic 
study, Study I, with findings published in Paper I, and one Web-based epidemiology study, 
Study II, with findings published in Paper II and Paper III. 
In Study I we validated a scored questionnaire, the Detrusor Instability Score (DIS). 
The study patients were first assessed by a urotherapist (a specialised nurse) by structured 
history taking and preliminary tests, prior to the consultation with a gynaecologist. The 
urotherapist used a non-validated, standardized multiple-choice form for obtaining the 
urological history, specially devised for urogynaecological problems. The DIS was 
embedded in this questionnaire, and was administered by the urotherapist in a clinical, 
gynaecological outpatient setting. The DIS is a validated scored questionnaire developed to 
detect detrusor instability, and consists of 10 items, to be scored between 0 and a maximum 
of 20 points. The resulting score was not calculated before the study was over, thus blinding 
the urotherapist and the gynaecologist to the DIS. Altogether 250 patients were included. 
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Urine samples were examined, and cultured if infected. The patients filled in 
frequency/volume-charts and performed pad-weighing tests at home, so that the results could 
be presented to the gynaecologist at the next consultation. The need for incontinence aids 
was also determined. 
The gynaecologist’s consultation consisted of the medical history, urogynaecological 
examination including the assessment of prolapse/atrophy, perinealneurological 
examination, measurement of the residual urine volume, palpation of the pelvic floor, 
including assessment of the active contraction ability, stress-test, urodynamic investigations, 
and urethrocystoscopy on special indications. The gynaecologist recorded two sets of 
diagnoses for research purpose, A: Urodynamic diagnosis, and B: Clinical diagnosis after a 
comprehensive assessment of all available data except the DIS. This comprehensive clinical 
assessment was defined to be the gold standard for diagnosing genuine stress incontinence 
(GSI). 
In Study I we found that the originally proposed cut-off level at 7 for the DIS 
resulted in patients with too many false positive findings for us to consider it to be useful as 
a preoperative tool. In 159 of the 250 women (64%) having GSI as defined diagnostically by 
a cut-off level at 7 for the DIS, we found that 41 of 250 women (16%) were actually given a 
false positive diagnosis. This could have been acceptable for conservative (non-surgical) 
treatments in primary health care settings, but not for surgical treatment. However, if the cut-
off level was lowered to a cut-off level at 5 for the DIS, we found that 112 of 250 women 
(45%) would be diagnosed as having GSI, with only 20 of 250 women (8%) having a false 
positive diagnosis. The important issue here was whether these women, if otherwise feasible 
and indicated, might be able to undergo continence surgery without preoperative 
urodynamics. Consequently, we concluded that a lower cut-off point than originally 
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proposed was needed for the DIS to become a useful preoperative tool for continence 
surgery. 
In Study II, we had two aims: To analyse how Web-based recruitment performed 
compared with postal surveys (Paper II), and to validate the International Consultation on 
Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) against the 
Incontinence Severity Index (ISI), in order to construct a severity grading for the ICIQ-UI 
SF (Paper III). We used the Web to invite a convenience sample of women to join a 
women’s health study by self-selected participation (n=1,812) in 2002. The study was 
performed using the software Inquisite. Female users of major Norwegian Web sites were 
asked to join the study by three different routes: a general health Web site (NettDoktor.no), 
the health section of a general-purpose Web portal (StartSiden.no), and the newspaper Web 
site of Verdens Gang (VG.no). By answering “Yes” to a question defining the respondent as 
having UI, the respondents were branched into two validated questionnaires, the ISI as items 
number 2 and 3 of the EPINCONT questionnaire on web page 4 (10 items), and the ICIQ-UI 
SF on web page 5 (four items). 
In Study II (Paper II), the results of 1,812 Web-recruited respondents were 
compared with 27,936 postally recruited study subjects, using the same epidemiological 
questionnaire to study UI as used in the EPINCONT study (Epidemiology of Incontinence in 
the County of Nord-Trøndelag). 
Comparative analysis of results of the corresponding variables used in the WEB-EPI 
UI and the EPINCONT studies was done by calculating the 95% CIs with the CIA 
software,[1] using the Newcombe method for comparing independent proportions. Single 
asterisks (*) were placed in Table 1 of Paper II to mark where the point estimate of one 
variable was not an element of the 95% CI of the corresponding variable, thus indicating a 
statistically significant difference. Double asterisks (**) were placed to mark where the 95% 
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CI for the difference between the independent proportions did not contain zero, indicating a 
statistically significant difference. 
The data were also analyzed as 5-year age groups, and for any significant difference 
for variables between the three different websites; none were detected, and the sample was 
analyzed as a whole. Statistical significance was accepted at the 5% level (P<0.05). 
We found that our Web sample of women with UI was younger than the EPINCONT 
sample, 37 versus 48 years, P<0.05. The proportion of women 60 years or older was only 
3.3% in our study, while it was 29.0% in the EPINCONT study. We found that the 
unadjusted prevalence of UI was lower in our study (20%) than in the EPINCONT study 
(25%), but age-stratified prevalence rates were higher in all age groups. In the Web sample, 
we found fewer women with slight UI in all age groups, and more with moderate (30-39 and 
50-59-year age groups) and severe UI (20-29, 30-39, and 40-49-year age groups).1 We 
concluded that we recruited a younger population with more severe UI than the EPINCONT 
study. Web-based approaches seem to be less feasible than postal methods for studies on 
conditions with higher prevalence in the older population, and UI is such a condition. 
In Study II (Paper III) we also performed a Web-based comparison of two scored 
questionnaires assessing the severity of UI, (the ICIQ-UI SF vs. the ISI), using the ISI as a 
gold standard. 
The ICIQ-UI SF has been developed by the International Consultation on 
Incontinence (ICI), has so far been translated to 38 languages, and is now recommended by 
the ICI as a gold standard outcome measure for future research and clinical practice, 
according to the proceedings of the 4th ICI (pp. 1771-2).[2] The committee recommends using 
                                                 
1 Erratum: In Paper II, the groups with severe UI were erroneously reported as 30-39, 40-49 
and 50-59. 
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high quality questionnaires (Grade A) for the assessment of the patient’s perspective of 
incontinence symptoms and their impact on quality of life, and recommend other Grade A 
questionnaires for more detailed assessment. 
We used split-half sampling for developing and validating the severity grading of the 
ICIQ-UI SF, using SPSS to extract a random half of the 343 women with UI, yielding a 
development sample (n=171) and a validation sample (n=172). The respondents in the first 
sample were used to develop the scale for the ICIQ-UI SF, while the remaining respondent 
sample was used to validate the severity scaling of the ICIQ-UI SF. Four levels of the ISI 
were plotted against the ICIQ-UI SF sum-score with and without the HRQoL dimension. 
The association between the ISI and ICIQ-UI SF scores was investigated by Spearman’s 
rank correlation coefficient (rho), as this correlation is used for ordinal variables. Kappa 
values were calculated using the SPSS on 4x4 contingency tables of the severity (slight, 
moderate, severe, very severe) of UI by arbitrarily changing the severity intervals until 
maximum Kappa was obtained. As SPSS was only able to produce unweighted Kappa 
statistics, the 4x4 contingency tables with maximum unweighted Kappa values produced by 
SPSS were manually entered into the Web pages provided by Professor emeritus Lowry, 
enabling us to calculate Kappa scores with linear and quadratic weighting. In order to create 
a scale for the ICIQ-UI SF based on the ISI as the assumed gold standard, we iteratively 
calculated the weighted Kappas for the unweighted Kappas that SPSS produced for the 
different intervals for the severity of the ICIQ-UI SF and the ISI. Accordingly, the weighted 
Kappas were calculated for the validation sample. 
There were strong correlations between the four-level ISI and ICIQ-UI SF scores 
with versus without the HRQoL item; Spearman’s rho was 0.62, P < 0.01 versus 0.71, P < 
0.01. By adjusting the intervals for the ICIQ-UI SF total score for the study subjects in the 
first scale development file to obtain maximum agreement with the four levels of the ISI, we 
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could define the following intervals for the ICIQ-UI SF (n = 171): slight (1-5), moderate (6-
12), severe (13-18), and very severe (19-21) (Kappa with quadratic weighting = 0.61). 
Similarly, for the ICIQ-UI SF without the HRQoL item, we could define the following 
levels: slight (1-3), moderate (4-5), severe (6-9), and very severe (10-11), (Kappa with 
quadratic weighting = 0.71). Applying these intervals to the second sample (n = 172) in 
order to validate our findings, Kappa with quadratic weighting for ICIQ-UI SF with and 
without the HRQoL item was 0.61 and 0.74, respectively. 
Our findings suggest that the ICIQ-UI SF may be divided into the following four 
severity categories: slight (1-5), moderate (6-12), severe (13-18) and very severe (19-21) UI. 
Disregarding the HRQoL-item, the four severity grades would be slight (1-3), moderate (4-
5), severe (6-9) and very severe (10-11). 
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Sammendrag (Abstract in Norwegian) 
Valideringer av forskningsmetoder for urininkontinens. 
Skårede spørreskjemaer i klinisk praksis og epidemiologisk forskning. 
Atle Klovning (Avhandling for graden philosophiae doctor, ph.d.). 
Mange klinikere og forskere har hevdet at det har vært utviklet for mange ulike 
spørreskjemaer for diagnostisering og vurdering av effekten av behandling av 
urininkontinens (UI), og at tiden er moden for å anbefale et avgrenset sett av validerte 
skårede spørreskjemaer. I løpet av de siste 25 årene har forskningsgruppen vår anvendt ulike 
strategier for å validere skårede spørreskjemaer til bruk i praksis og epidemiologisk 
forskning på UI. 
Denne ph.d.-avhandlingen bygger på resultatene fra to studier; en klinisk 
diagnostikkstudie, Studie I, med funn publisert i Artikkel I, og en Web-basert analytisk 
epidemiologistudie, Studie II, med funn publisert i Artikkel II og Artikkel III. 
I Studie I validerte vi et spørreskjema, Detrusor Instability Score (DIS). Pasientene 
ble først vurdert av en uroterapeut (en spesialisert sykepleier) ved hjelp av et ikke-validert, 
strukturert anamneseskjema og med innledende tester, forut for konsultasjonen med en 
gynekolog. Uroterapeuten brukte et standardisert flervalgsskjema for å ta opp den urologiske 
anamnesen, spesielt utviklet for urogynekologiske problemer. DIS var bygget inn i dette 
spørreskjemaet som ble administrert av en uroterapeut på en gynekologisk poliklinikk. DIS 
er et validert, skåret spørreskjema utviklet for å detektere detrusor instabilitet, og består av 
10 elementer, og som skal skåres 0-20 poeng. Poengsummen ble ikke beregnet før studien 
var over, og dermed var både gynekologen og uroterapeuten blindet for DIS. Til sammen 
250 pasienter ble inkludert. 
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Urinprøver ble undersøkt, og dyrket dersom infisert. Pasientene fylte ut miksjonsliste 
og utførte bleieveiingstester hjemme, slik at resultatene kunne forelegges gynekologen ved 
neste konsultasjon. Behovet for inkontinenshjelpemidler ble også vurdert. 
Gynekologens konsultasjon omfattet anamneseopptak, urogynekologisk undersøkelse 
inkludert vurdering av prolaps/atrofi, perinealneurologisk undersøkelse, måling av resturin, 
palpasjon av bekkenbunnen, inkludert vurdering av bekkenbunnsmuskulatur, stresstest, 
urodynamiske undersøkelser, og urethracystoskopi på spesielle indikasjoner. Gynekologen 
registrerte to sett med diagnoser for forskningsformål, A: Urodynamisk diagnose og B: 
Klinisk diagnose etter en helhetlig vurdering av alle tilgjengelige data bortsett fra DIS. 
Denne helhetlige,  kliniske vurderingen ble definert å være gullstandarden for 
diagnostisering av genuin stressinkontinens (GSI). 
I Studie I fant vi at den opprinnelig foreslåtte avskjæringsverdien ved 7 for DIS førte 
til for mange falske positive funn til vi kunne anse DIS å være nyttig som et preoperativt 
verktøy. Hos 159 av 250 kvinner (64%) som hadde GSI definert ved en avskjæringsverdi på 
7 for DIS, fant vi at 41 av 250 kvinner (16%) faktisk fikk en  falsk positiv diagnose. Dette 
kunne tenkes å være akseptabelt for konservativ (ikke-kirurgisk) behandling i 
primærhelsetjenesten, men ikke for kirurgisk behandling. På den andre siden, dersom 
avskjæringsverdien for DIS ble senket til 5, ville det resultert i at 112 av 250 kvinner (45%) 
fikk definert diagnosen GSI, hvorav 20 av 250 kvinner (8%) fikk en falsk positiv diagnose. 
Det sentrale spørsmålet her var om disse kvinnene, dersom det ellers var indisert, kunne 
tilbys kontinenskirurgi uten preoperativ urodynamisk undersøkelse. Som en følge av våre 
beregninger, fant vi at et lavere avskjæringspunkt enn det opprinnelig foreslåtte var 
nødvendig om DIS skulle kunne være et nyttig verktøy for preoperativ vurdering før 
kontinenskirurgi. 
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I Studie II, hadde vi to mål: å analysere hvordan Web-basert rekruttering 
funksjonerte sammenlignet med brevbaserte undersøkelser (Artikkel II), samt å validere 
spørreskjemaet International Consultation on Incontinence Questionnaire-Urinary 
Incontinence Short Form (ICIQ-UI SF) mot Incontinence Severity Index (ISI), for deretter å 
utarbeide en alvorlighetsgradering av ICIQ-UI SF (Artikkel III). Vi brukte WWW til å 
invitere et selvselektert utvalg kvinner (n=1812) i 2002 til å delta i en 
kvinnehelseundersøkelse. Studien ble utført ved hjelp av programvaren Inquisite. Kvinnelige 
brukere av store norske Websteder ble rekruttert via tre forskjellige ruter: et generelt 
helsewebsted (NettDoktor.no), helseseksjonen av webportal (StartSiden.no), og nyhetsweben 
VG.no. Ved å svare bekreftende på et spørsmål som definerte at respondenten hadde UI, ble 
respondentene forgrenet til to validerte spørreskjemaer, ISI som spørsmål 2 og 3 i 
EPINCONT på web side 4 (10 spørsmål), og ICIQ-UI SF på web side 5 (fire spørsmål). 
I Studie II (Artikkel II) ble resultatene fra 1 812 Webrekrutterte respondenter 
sammenlignet med 27 936 brevrekrutterte respondenter, med det samme epidemiologiske 
spørreskjemaet som ble brukt i EPINCONT studien (Epidemiology of Incontinence in the 
County of Nord-Trøndelag). 
Alle konfidensintervallene ble beregnet etter Newcombes metode for å sammenligne 
uavhengige proporsjoner ved hjelp av et MS DOS-basert program, CIA.[1] Alle 
konfidensintervallene ble beregnet én og én, og tilordnet stjerner etter sammenligning av 
konfidensintervallene for EPINCONT og WEB-EPI UI studiene. En enkeltstjerne (*) 
markerte i Tabell 1 i Artikkel II de tilfellene hvor punktestimatet av en variabel ikke var 
delmengde av 95% konfidensintervallet til den korresponderende variabelen, og således 
indikerte en statistisk signifikant forskjell. Dobbeltstjerner (**) markerte de tilfellene hvor 
95% konfidensintervallet for forskjellen mellom uavhengige proporsjoner ikke inneholdt 
null, og dermed indikerte en statistisk signifikant forskjell. 
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Dataene ble også analysert som 5-års aldersgrupper, og for statistisk signifikante 
forskjeller mellom deltagerne fra de tre forskjellige webstedene; ingen forskjeller ble 
avdekket, slik at utvalget ble analysert som et hele. Statistisk signifikans ble akseptert på 5% 
nivået (P<0,05). 
Webrespondentene var yngre enn EPINCONT-respondentene, 37 versus 48 år, 
P<0,05. Andelen kvinner 60 år eller eldre var bare 3,3% i vår undersøkelse, mot 29,0% i 
EPINCONT studien. Vi fant at den ujusterte råprevalensen av kvinner med UI var lavere i 
vår studie (20%) enn i EPINCONT studien (25%), mens den aldersstratifiserte prevalensen 
var høyere i de enkelte aldersgruppene. I Web-gruppen fant vi færre kvinner med mild UI i 
alle aldersgrupper, og flere med moderat (30-39 og 50-59-års aldersgrupper) og alvorlig UI 
(20-29, 30-39 og 40-49-års aldersgrupper).2 Vi konkluderte med at vi rekrutterte en yngre 
populasjon av kvinner med mer alvorlig UI enn EPINCONT studien. Web-baserte 
tilnærminger synes å være mindre hensiktsmessige enn postale metoder for studier av 
tilstander med høyere prevalens i den eldre delen av befolkningen, og UI er en slik tilstand. 
I Studie II (Artikkel III) gjennomførte vi også en Web-basert sammenligning av to 
skårede spørreskjemaer som vurderer alvorlighetsgraden av UI, ICIQ-UI SF og ISI, hvor vi 
anvendte ISI som gullstandarden. 
ICIQ-UI SF er utviklet av The International Consultation on Incontinence (ICI), og 
har så langt blitt oversatt til 38 språk, og er nå anbefalt av ICI som gullstandarden for 
fremtidig forskning og klinisk praksis, ifølge rapporten fra den 4de ICI (side 1771-2).[2] 
Komiteen anbefaler bruken av høykvalitets spørreskjemaer (Grad A) for vurdering av 
                                                 
2 Erratum: I Artikkel II er gruppen med ”severe UI” feilaktig beskrevet som 30-39, 40-49 og 
50-59. 
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pasientens egne syn på urininkontinenssymptomene og deres betydning for livskvaliteten, og 
anbefaler andre Grad A spørreskjemaer for mer detaljerte vurderinger. 
Vi anvendte splittmetodikk for å lage et utviklings- og et valideringsutvalg for 
alvorlighetsgradering av ICIQ-UI SF, ved å bruke SPSS til å splitte utvalget bestående av 
343 kvinner med UI i to tilfeldige halvdeler, slik at vi fikk et utviklingsutvalg på 171 og et 
valideringsutvalg på 172 respondenter. Respondentene i det første utvalget ble brukt til å 
utvikle graderingsskalaen for ICIQ-UI SF, mens den gjenværende halvdelen ble brukt til å 
validere denne alvorlighetsskalaen. Fire nivåer av ISI ble plottet mot ICIQ-UI SF skåren 
med og uten livskvalitetsdimensjonen. Assosiasjonen mellom ISI og ICIQ-UI SF ble 
undersøkt ved hjelp av Spearman’s rank correlation coefficient (rho), ettersom metoden 
brukes for ordinale variabler. Kappaverdier ble beregnet ved hjelp av SPSS for 4x4-tabeller 
av alvorlighetsgrader (mild, moderat, alvorlig og svært alvorlig) av UI ved å systematisk 
endre alvorlighetsintervallene inntil maksimal Kappaverdi ble funnet. Siden SPSS bare var i 
stand til å produsere uvektet Kappastatistikk, ble de 4x4-tabellene med maksimal uvektet 
Kappa manuelt lagt inn i et webbasert program utviklet av professor emeritus Lowry, slik at 
vi kunne regne ut Kappaverdier med bade lineær og kvadratisk vekting. For å skalere ICIQ-
UI SF basert på ISI som den antatte gullstandarden, beregnet vi gjentatte ganger vektet 
Kappa for de uvektede 4x4-tabellene som SPSS produserte for de forskjellige 
alvorlighetsintervallene av ICIQ-UI SF og ISI. Til slutt ble vektede Kappaverdier for 
valideringsutvalget beregnet. 
Vi fant høy korrelasjon mellom fire-nivå ISI og ICIQ-UI SF skårene med versus uten 
livskvalitetsdelen, Spearmans rho var 0,62 (P < 0,01) versus 0,71 (P < 0,01). Ved å justere 
intervallene for ICIQ-UI SF totalskår for forsøkspersonene i utviklingsfilen for å oppnå 
maksimum overensstemmelse med de fire gradene av ISI, fant vi følgende intervaller for 
ICIQ-UI SF (n = 171): mild (1-5), moderat (6-12), alvorlig (13-18), og svært alvorlig (19-21) 
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(Kappa med kvadratisk vekting = 0,61). Tilsvarende, for ICIQ-UI SF uten livskvalitetsdelen, 
fant vi følgende nivåer: mild (1-3), moderat (4-5), alvorlig (6-9), og svært alvorlig (10-11), 
(Kappa med kvadratisk vekting = 0,71). Ved å anvende disse intervallene på valideringsfilen 
vår (n = 172), fant vi at Kappa med kvadratisk vekting for ICIQ-UI SF med og uten 
livskvalitetsdelen var henholdsvis 0,61 og 0,74. 
Våre funn viste at total ICIQ-UI SF kan deles inn i følgende fire alvorlighetsgrader: 
mild (1-5), moderat (6-12), alvorlig (13-18) og svært alvorlig (19-21) UI, og dersom vi ikke 
tar med livskvalitetsdelen, blir graderingen mild (1-3), moderat (4-5), alvorlig (6-9) og svært 
alvorlig (10-11). 
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Abbreviations and definitions 
Accuracy Rate of true positives and true negatives 
AUC Area under the curve 
BMI Body mass index 
CI Confidence interval 
DARE Database of Abstracts of Reviews of Effects 
DI Detrusor instability (outdated). Idiopathic detrusor 
overactivity 
DIS Detrusor instability score 
DO Detrusor overactivity 
DOR Diagnostic odds ratio 
EAEMP European agency for the evaluation of medicinal 
products 
EBLM Evidence-based laboratory medicine 
EBM Evidence-based medicine 
EPINCONT Epidemiology of Incontinence in the County of Nord-
Trøndelag 
FDA Food and Drug Administration 
GSI Genuine stress incontinence (outdated) 
HRQoL Health Related Quality of life 
HTA Health Technology Assessment 
HTML HyperText Markup Language 
ICC Intra-class correlation 
ICI International Consultation on Incontinence 
ICIQ-UI SF International Consultation on Incontinence 
Questionnaire-Urinary Incontinence Short Form 
ICS International Continence Society 
ICUD International Consultation on Urologic Diseases 
IIQ Incontinence Impact Questionnaire 
Internet The physical network that interconnects computers in 
order to deliver services like the WWW 
Intranet A physical network, often password protected, that 
delivers services to local users at offices 
IPSS International prostate symptom score 
ISI Incontinence Severity Index 
ISP Internet Service Provider 
IUGA International Urogynecological Association 
JAMA Journal of the American Medical Association 
Kappa Statistical method for assessing inter-observer agreement 
KHQ King’s Health Questionnaire 
LR- Negative likelihood ratio 
LR+ Positive likelihood ratio 
LUTS Lower urinary tract symptoms 
MCU Multichannel urodynamics 
MUI Mixed urinary incontinence 
MySQL A relational database management system 
N&U Neurourology and Urodynamics 
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NHS National Health Service 
NICE National Institute for Health and Clinical Excellence 
NPV Negative Predictive Value, the proportion of patients with a 
negative test not having the disease 
OAB Overactive bladder 
OCR Optical character recognition 
OR Odds ratio 
MS-DOS Microsoft Disk Operating System 
PASW Statistics 18.0 Now IBM SPSS Statistics: www.spss.com/ibm-
announce/  
PFD Pelvic floor dysfunction 
POP Pelvic organ prolapse 
PPV Positive Predictive Value, the proportion of patients with a 
positive test having the disease 
Prevalence The proportion of patients having a disease 
PRO Patient reported outcome, see 1.1.3 for details 
PRO-questionnaires Patient reported outcome questionnaires 
QoL Quality of life, shorter form for HRQoL 
R&D Research and development 
RAND A contraction of the term research and development. 30 
Nobel Laureates have been affiliated with this US 
corporation. http://www.rand.org/about/history/  
ROC Receiver operating characteristics 
RR Relative risk 
SD Standard deviation 
s.e.m Standard error of the mean 
Sensitivity The proportion of patients with a disease having a positive test 
(=True positive rate) 
SnNout For a high sensitivity (≥80%) a negative test rules out the 
condition 
Specificity The proportion of patients with no disease having a negative 
test (=True negative rate) 
SpPin For a high specificity (≥80%), a positive test rules in the 
condition 
SPSS Statistical package for the social sciences, now PASW 
Statistics 18.0 
sROC Summary receiving operating characteristic 
SUI Stress urinary incontinence 
UDI Urodynamic investigation 
UI Urinary incontinence 
Urodynamics Functional study of the lower urinary tract 
USI Urodynamic stress incontinence (formerly GSI) 
UTI Urinary tract infection 
UUI Urgency urinary incontinence 
WEB-EPI UI Web-based epidemiology of urinary incontinence 
WHO World Health Organization 
WWW World Wide Web, service delivered for use on the 
Internet 
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1 Introduction 
1.1 The ICS definition of UI 
1.1.1 From “Social and hygienic problem, objectively demonstrable” to 
“Any leakage” 
The original ICS definition of UI 
In 1988, the International Continence Society committee on standardisation of 
terminology of lower urinary tract function defined UI as “involuntary loss of urine, 
which is objectively demonstrable and a social or hygienic problem.”[3] In accordance 
with this, the consensus statement at the 1st International conference for the prevention 
of incontinence proposed the following statement in 19973: 
“Since there are numerous definitions of Urinary Incontinence, it was agreed 
that the International Continence Society definition be adopted by the 
Conference: Urinary Incontinence is a condition in which involuntary urine loss 
is a social or hygienic problem and is objectively demonstrable. However, the 
'objectively demonstrable' criteria may require modification in large-scale 
epidemiological work.” 
A simple Google-search (March 2010) for the definition of “urinary incontinence” 
showed that many Web sites still continue to use the original definition, thus 
misleading the Web community. 
                                                 
3 http://www.continence-foundation.org.uk/in-depth/prevention-of-incontinence.php 
 2 
The ICS Committee on Standardisation of Terminology 
The ICS has gone through many processes in the different phases of standardising the 
terminology related to LUTS. The reports have been published in parallel (dual 
publication) in several journals to reach the relevant specialist milieus: urologists, 
gynaecologists and urogynaecologists. The First,[4, 5] Second,[6-8] Third,[9-11] Fourth,[12, 
13] Sixth,[3, 14, 15] and Seventh report[16] have been published in urological and 
gynaecological journals. The Fifth seems to be missing; it has not been published as 
far as I can see from my literature searches. The latest version of the terminology was 
published in January 2010, and is from now on a joint effort between the IUGA and 
the ICS (see section 1.1.2).[17, 18] 
Criticism of the original ICS definition 
Foldspang and Mommsen argued strongly against the original ICS definition in a 
study published in the Journal of Clinical Epidemiology in 1997.[19] They showed that 
it was problematic that UI had to be “objectively demonstrable,” and incorrect to 
define UI as “being a social and hygienic problem” instead of just “any leakage.” 
They based their conclusion on results from conducted a postal, cross-
sectional, age-stratified study of 3,114 women in Aarhus, Denmark, and found that 
only 63% of 388 women considered UI to be a “social or hygienic problem,” and only 
22% conformed that they had ever abstained socially because of UI. The authors 
concluded that the ICS definition of UI at that time presented intrinsic logical 
problems that invalidated its use in research. 
In 1998, Holtedahl and Hunskaar demonstrated the effect different definitions 
of UI had on prevalence rates, when applied to the same population of women.[20] In 
this study, 47% reported “any incontinence,” 31% reported leakage twice or more 
often per month, while only 19% admitted incontinence as defined by the ICS. 
  3 
Criticism of the original definition was also raised in the epidemiology 
sections in the proceedings from the meetings of the 1st ICI[21] (pp. 216-7) held in 
Monaco in 1998 and the 2nd ICI[22] (pp. 194-5) held in Paris in 2001, and onwards. In 
the latter publication, it was the Committee on Epidemiology, chaired by Professor 
Steinar Hunskaar that very clearly stated that there was a need to change the ICS 
definition of UI to “any leakage.” The committee further suggested that 
epidemiological studies should contain a minimum data set consisting of a screening 
question for UI (“any leakage”), frequency and quantity measures, duration, type and 
severity. In addition, using bother- or HRQoL-measures was recommended. 
Acknowledging these criticisms, the ICS definition was changed in 20014, and 
has since then been phrased as “the complaint of any involuntary leakage of urine.”[23] 
In the 3rd ICI on page 298, the process of accepting UI as “any leakage” was 
discussed.[24] 
1.1.2 The present (2010) IUGA/ICS joint terminology 
The joint report on the terminology for female PFD (pelvic floor dysfunction) was 
presented in the January 2010 issue of N&U.[17, 18] The authors clearly stated that 
there was a need for a core terminology for clinical use and research, and that this 
terminology had to be “female-specific”. The authors argued that such a report should 
also be as user-friendly as possible, clinically based, able to indicate origin of the 
term, and to provide explanations. 
The joint report further divides the terminology into “Symptoms,” “Signs,” 
and “Urodynamic investigations and associated pelvic imaging,” and left out the 
                                                 
4 Erratum: The paper referred to says 2002; 2001 is the correct year (e-mail from 
Professor Steinar Hunskaar) 
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terms “Urodynamic observation” and “Conditions.” The joint IUGA/ICS terminology 
report[17] defines the following UI symptoms (The abbreviations below are my 
suggestions): 
UI symptoms 
(i) Urinary incontinence (symptom): Complaint of involuntary loss of 
urine. (UI) 
(ii) Stress (urinary) incontinence: Complaint of involuntary loss of urine 
on effort or physical exertion (e.g., sporting activities), or on sneezing 
or coughing. N.B.: “activity-related incontinence” might be preferred 
in some languages to avoid confusion with psychological stress. (SUI) 
(i) Urgency (urinary) incontinence: Complaint of involuntary loss of 
urine associated with urgency. (UUI) 
(ii) Postural (urinary) incontinence: (NEW) Complaint of involuntary loss 
of urine associated with change of body position, for example, rising 
from a seated or lying position. (PUI) 
(iii) Nocturnal enuresis: Complaint of involuntary urinary loss of urine 
which occurs during sleep. (NE) 
(iv) Mixed (urinary) incontinence: Complaint of involuntary loss of urine 
associated with urgency and also with effort or physical exertion or on 
sneezing or coughing. (MUI) 
(v) Continuous (urinary) incontinence: Complaint of continuous 
involuntary loss of urine. (CUI) 
(vi) Insensible (urinary) incontinence: (NEW) Complaint of urinary 
incontinence where the woman has been unaware of how it occurred. 
(IUI) 
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(vii) Coital incontinence: (NEW) Complaint of involuntary loss of urine 
with coitus. This symptom might be further divided into that occurring 
with penetration or intromission and that occurring at orgasm. (CoI) 
Bladder storage symptoms 
(i) Increased daytime urinary frequency: Complaint that micturition 
occurs more frequently during waking hours than previously deemed 
normal by the woman. 
(ii) Nocturia: Complaint of interruption of sleep one or more times 
because of the need to micturate (void). 
(iii) Urgency: Complaint of sudden compelling desire to pass urine, which 
is difficult to defer. 
(iv) Overactive bladder: (OAB, urgency) syndrome: Urinary urgency, 
usually accompanied by frequency and nocturia, with or without 
urgency urinary incontinence, in the absence of UTI or other obvious 
pathology. 
UI signs 
Signs are defined as any abnormality indicative of disease or a health problem, 
discoverable on examination of the patient by health care workers; an objective 
indication of disease or a health problem. The urinary incontinence signs are defined 
as: 
(v) Urinary incontinence: Observation of involuntary loss of urine on 
examination: this may be urethral or extraurethral. 
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(vi) Stress (urinary) incontinence (clinical stress leakage): Observation of 
involuntary leakage from the urethra synchronous with effort or 
physical exertion, or on sneezing or coughing. 
(vii) Urgency (urinary) incontinence: Observation of involuntary leakage 
from the urethra synchronous with the sensation of a sudden, 
compelling desire to void that is difficult to defer. 
(viii) Extraurethral incontinence: Observation of urine leakage through 
channels other than the urethral meatus, for example, fistula. 
(ix) Stress incontinence on prolapse reduction (occult or latent stress 
incontinence): (NEW) Stress incontinence only observed after the 
reduction of co-existent prolapse. 
UI diagnoses 
As a consequence of these new definitions, the report highlights six diagnoses that are 
common in the sense that there is evidence for a prevalence of 10% or more in women 
presenting with symptoms of PFD (pelvic floor dysfunction). These six are: 
(i) Urodynamic Stress Incontinence. (USI) 
(ii) Detrusor Overactivity. (DO), replaces detrusor instability. 
(iii) Bladder Oversensitivity. (BO), increased bladder sensitivity, replaces 
sensory urgency. 
(iv) Voiding Dysfunction (VD), 
(v) Pelvic Organ Prolapse (POP) and 
(vi) Recurrent UTIs. 
The joint report also includes definitions for other related PFDs, but these are outside 
the scope of this thesis, and therefore not mentioned here. 
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The group suggested that future publications should acknowledge these 
standards in the “Methods and Materials” section of any publication with this exact 
text: 
“Methods, definitions and units conform to the standards jointly recommended 
by the International Incontinence Society (ICS) and the International 
Urogynecological Association, except where specifically noted.” 
As a curiosity, I remark that the text is erroneous, and should have been phrased  
“International Continence Society” and not “International Incontinence Society.” 
1.1.3 Future assessment: From urodynamics to Patient Reported 
Outcome questionnaires? 
A patient reported outcome (PRO) is defined as any report coming directly from 
patients, without prior interpretation by physicians or anyone else, about how they 
function or feel in relation to a disease or treatment.[25] It seems that the technology 
optimism that had been associated with urodynamic investigations, probably due to 
the former definition requiring the documentation of objectively demonstrable UI, has 
now seemingly turned in favour of using PRO-questionnaires to a larger extent for 
clinical practice and research. 
Patient reported outcome (PRO)-questionnaires have now been proposed as a 
preferred choice for use in clinical practice and research by the 4th ICI, as validated 
instruments applying non-invasive methods for assessing UI.[2] This committee 
strongly advocates the use of PRO-questionnaires in the chapter ”Initial assessment of 
urinary and faecal incontinence in adult male and female patients” as their 
contribution to the proceedings,[26] and this document fully replaces the earlier 
versions produced by the first three ICI scientific committees led by Jenny 
Donovan,[27-29] whose reports had pioneered the evidence-rating of all questionnaires 
that had been developed, grading them from A to C. 
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In the UK, the National Institute for Health and Clinical Excellence (NICE) 
have produced many guidelines, also for UI, in full text versions, shorter versions and 
“pullouts.”[30-34] The NICE also recommends the use of questionnaires, and 
emphasizes that the initial assessment and treatments should be done in primary care 
settings. The 2006 NICE guideline[30] on UI provides strategies for the evaluation and 
management of stress incontinence. In this guideline, the NICE argues that that there 
is no need for invasive diagnostic procedures like UDIs prior to instigating 
conservative treatments in women with pure SUI. 
Dmochowski criticized this view in an editorial,[35] based on the findings of a 
large, but retrospective audit study by Digesu et al.:[36] “Do women with pure SUI 
need urodynamics?” Digesu et al. studied 3,428 women aged 24-81, and of these, 
52% complained of urinary incontinence, whereas 48% self-reported to be continent. 
Only 308 women (9%) could be classified as having pure SUI. Of the 308 women 
who complained of having only SUI, 78% had USI, 8% had DO, 3% had combined 
USI and DO, and 11% had inconclusive urodynamics (no urodynamic abnormality). 
The women with inconclusive urodynamics were investigated further with 
urethrocystoscopy and/or ambulatory urodynamics. Ambulatory urodynamic 
evaluations revealed that all of these women had DO. The authors therefore conclude 
that since nearly 20% of the women with pure SUI according to the KHQ in fact have 
DO, this group needs different treatment options or management. I do not consider 
this to be problematic. The challenge of finding the 20% with DO still needs to be 
catered for, before operative procedures are considered. But for conservative 
measures, this is not so. In Study I we found only 8% with DI if the cut-off level was 
set to 5 for the DIS, while it was 20% for the KHQ, based on the symptoms domain of 
the KHQ. 
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In a review conducted by Avery et al.[37] based on a literature search in 
relevant databases until 2004, applying the same standardized recommendation grades 
as used in the 4th ICI book,[26] they found 150 randomized trials, investigating 130 
treatments of UI. Interestingly, only 50 (38%) of the trials included a grade A 
questionnaire as an outcome measure, and only 25 (19%) of these trials included 
grade A questionnaires that were considered to attain the highest level of rigour. 
Researchers should keep in mind that considerable advances have been made in the 
non-invasive assessment of urinary incontinence, with 18 questionnaires now 
achieving the highest level (grade A) of scientific rigour.[37] The assessment of UI 
symptoms and its impact on patient lives is now characterized by high quality, 
validated questionnaires and more consistent use of these instruments in RCTs, 
facilitating future cross-comparison of results between studies. 
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1.2 Scored questionnaires 
In 1994, Professor Abrams postulated the basic requirements for useful 
questionnaires. The questionnaires had to be facile, each item should demonstrate a 
causal relationship with the condition to be measured, the score should be able to 
assist in determining the appropriate treatment, and finally, use of the questionnaire 
should improve patient care.[38] 
In addition, there was a need for evidence-grading and quality assessment of 
already developed instruments. As part of this process, the ICS adopted the ICUD-
process that led to the development of the International prostate symptom score 
(IPSS). Accordingly, this led to a series of International Consultations on 
Incontinence (ICIs). 
1.2.1 The process of EBM-grading scored questionnaires 
The 1st International Consultation on Incontinence (Monaco, 1998) 
The first detailed expert-based review of recommended questionnaires for use in 
assessing UI was provided in 1999 in the proceedings (book) of the 1st International 
Consultation on Incontinence held in Monaco in 1998,[39] sponsored by the WHO and 
organized by the ICS and ICUD, WHO-recognized, non-governmental organisations. 
The 1st ICI followed an organisational template that has been used in all 
ICUD-consultations from 1991 and onwards in order to produce a book combining 
consensus methods with methods of systematic reviews.[39] First, the ICS appoints an 
ICI Executive Committee which, in consultation with the major relevant scientific 
societies worldwide, appoints an appropriate range of committees to cover the topic of 
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the individual consultation. Next, the ICI Executive Committee appoints chairs and 
scientific committee members with broad academic qualities, representative of the 
global scientific community and relevant specialties. Each committee is responsible 
for defining its subject matter. In the 12-month period prior to the next consultation, a 
systematic review of the relevant medical literature is performed, as a basis for the 
content of the committee’s chapter. Usually, at least three drafts are written and 
reviewed by the committee members at preliminary meetings, typically held at the 
American Urological Association or the European Association of Urology, in advance 
of the final meeting at the consultation itself. At this consultation, the committee chair 
presents the final draft of this chapter, which is then edited and published as a book 
chapter, together with the work of the other committees. Each ICI scientific 
committee, consisting of the Executive Committee and the chairs of the individual 
committees, provide a series of recommendations for the investigation and treatment 
of patients, based on the findings of the respective committees at the end of the 
consultation, and these are formulated in the final book chapters. 
The 1st ICI appointed 24 individual committees, including a committee on 
“Symptom and QoL-assessment” relevant for this thesis. The committee members 
applied grades of recommendations to already developed questionnaires based on 
their type of validation, and encouraged the use of questionnaires with the highest 
possible level of recommendation, both in clinical practice and for research on UI. 
The 2nd International Consultation on Incontinence (Paris, 2001) 
At the Second International Consultation on Incontinence in Paris in 2001, the 
scientific committee developed standardised grades of recommendation for all 
questionnaires,[28] attempting to reflect the Levels of Evidence devised by the Oxford 
Centre for Evidence Based Medicine. These were applied to evaluate questionnaires 
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concerning urinary incontinence. At the 2nd ICI, the scientific committee had devised 
three grades of recommendations:[28] 
A: Questionnaires were “Highly recommended” and given a Grade A if the 
committee found that published data indicating that the questionnaire was valid, 
reliable and responsive to change following standard psychometric testing. Evidence 
had to be published on all three aspects, and questionnaires had to be relevant for use 
in persons with incontinence. 
B: Questionnaires were “Recommended” and given a Grade B if the 
committee found published data indicating that the questionnaire was valid and 
reliable following standard psychometric testing. Evidence had to be published on two 
of the three main aspects, usually validity and reliability. 
C: Questionnaires were considered to have “Potential” and given Grade C if 
the committee found published data (including abstracts) indicating that the 
questionnaire was valid or reliable or responsive to change following standard 
psychometric testing. 
The 3rd International Consultation on Incontinence (Paris, 2004) 
At the 3rd ICI,[29] these grades were yet revised and updated to take into account the 
increasing numbers of published questionnaires concerned with LUTS and 
incontinence, and also broadening of the field to include pelvic organ prolapse (POP) 
and faecal incontinence. 
The 4th International Consultation on Incontinence (Paris, 2008) 
The book of the 4th ICI represented a very marked shift in the recommendations,[26] as 
the ICI scientific committee recommended that no other questionnaires other than the 
relevant ICIQ modules were to be used, apart from at very special occasions. The ICI 
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scientific committee argued that the number of high quality questionnaires already 
having been developed was too high, and meant that there were now sufficient 
questionnaires for most purposes, so it was not necessary to encourage the 
development of new questionnaires, except for particular patient groups. The ICI 
scientific committee expected that at the time of the next ICI, “Grade A new” 
questionnaires would either be promoted to “Grade A” because of further high quality 
publications or relegated to Grade B if further development did not occur. 
Although the 4th ICI represented a change of direction from the previous 
recommendation schemes, questionnaires would still be graded A, B, or C as outlined 
earlier. Within the description of the ICIQ modular structure (see 1.2.2), the grade 
assigned to each module would be indicated. In case none of the modular 
questionnaires were found appropriate for specific research or clinical purposes, the 
ICI’s recommendation was to use a Grade A questionnaire as previously 
recommended; and where no suitable instrument existed- a Grade B or C 
questionnaire. The new grading criteria are shown in the documents Table 1 from the 
document:[2] 
 
This version also introduces a new concept: For UI and UI/LUTS, the scientific 
committees examined the quality of the psychometric evidence. Only where published 
data were scientifically sound was the label ‘with rigour’ allowed. 
In Study II we have used the ISI and ICIQ-UI SF questionnaires (described in 
greater detail in chapters 1.2.3 and 1.2.4); both are Grade A questionnaires. 
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1.2.2 The ICIQ Modular structure 
Acknowledging the fact that there has been a need for universally applicable PFD-
questionnaires that could be widely applied across the population for clinical practice 
and research, the 1st ICI scientific committee initiated in 1999 the development of a 
set of questionnaires that would facilitate the cross-comparisons of findings from 
different settings and studies in a manner similar to that of the International Prostate 
Symptom Score (IPSS).[39] Hence, the 1st ICI scientific committee decided to develop 
the ICIQ-modules according to the standard methods of psychometric testing outlined 
by the “Symptom and QoL assessment” committee.[27] 
The ICIQ Advisory Board was formed in 1999, and the project was discussed 
with the board, and early in the process a decision was made to extend the concept 
further and develop the ICIQ Modular Questionnaire. The first questionnaire to be 
developed in this module was the ICIQ-UI SF for urinary incontinence, which has 
now been fully psychometrically validated.[40] 
Given the initial intent to produce an internationally applicable questionnaire, 
the Advisory Board developed a protocol for the production of translations of its 
modules. This protocol prescribes the production of the new language version by 2 
native speakers of the target language (step 1), back translation into the source 
language (English) by a native English speaker (step 2), resolution of any differences 
between the original and the language version (step 3), and revalidation of the new 
language version. If backward translation is not successful, it is suggested that the 
questionnaire may need validation in that language.[25, 39] As of May 2010, the ICIQ-
UI SF has been translated into 38 languages,[25] among them Italian,[41] Japanese,[42] 
Spanish[43] and Arabic.[44] 
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The production of new questionnaires is extremely time-consuming and 
costly. Based on the recommendations of the “Symptom and QoL assessment” 
committee at the 1st and 2nd ICI consultations in 1998 (Monaco) and 2001 (Paris), a 
number of already existing validated questionnaires have been adopted as ICIQ 
modules and renamed with the permission of their authors. For the first 5 years after 
inclusion as ICIQ modules, it has been recommended that the original questionnaire 
should be cited in any ICIQ publications. 
In the proceedings of the 4th ICI (2008),[26] Table 3 in that text (see below) 
shows the ICIQ modular structure, with existing modules, modules that are being 
developed for urinary tract, vaginal and lower bowel symptoms, and additional 
modules that are condition specific, dealing e.g. with sexual matters and HRQoL. 
Eventually, patient satisfaction modules will also be developed, as an important part 
of assessing treatment effectiveness. The ICIQ modules will eventually evolve into 
grade A with rigour of all modules as the validation process continues. 
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1.2.3 The ICIQ-UI SF (Appendix 3 and 4) 
The ICIQ-UI SF is a sum-score developed by the International Consultation on 
Incontinence Modular Questionnaire study group (www.iciq.net).[39] This 
questionnaire is the UI element in a modular package of questionnaires for related 
PFD problems. Avery et al. have psychometrically validated the ICIQ-UI SF, in a 
paper that in a transparent manner describes the validation process of the ICIQ-UI SF, 
the thoroughness and completeness all of the modules of the ICIQ have to undergo.[40] 
The ICIQ-UI SF is developed for assessing the prevalence, severity, impact on quality 
of life, and type of UI. Two studies have compared the ICIQ-UI SF with urodynamics 
since its introduction in 1999.[45, 46] The ICIQ-UI SF has been translated to 38 
languages,[25] among them Norwegian, Swedish, Danish and Finnish. It has undergone 
many validation studies, and has been used in many different types of studies. The 
ICIQ-UI SF has received the highest grade of recommendation by the committees of 
the 2nd and 3rd International Consultations on Incontinence,[28, 29] and is now 
recommended by the ICI as a gold standard outcome measure for future research and 
clinical practice, according to the proceedings of the 4th ICI (pp. 1771-2).[2] The 
committee recommends using high quality questionnaires (Grade A) for the 
assessment of the patient’s perspective of incontinence symptoms and their impact on 
quality of life, and recommend other Grade A questionnaires for more detailed 
assessment. 
The ICIQ-UI SF consists of four items. Only the first three items are part of 
the sum score. The fourth item included was meant to be a self-assessment of the 
aetiology, and was included by the expert committee because it was thought to be 
useful in clinical practice, to understand patients’ perception of the cause and type of 
leakage. This part of the questionnaire has not been subjected to validation processes. 
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The third item was constructed as an HRQoL-scale, in the form of a VAS ranging 
from 0 (“not at all”) to 10 (“a great deal”). 
The complete form we used in Norwegian is shown in Appendix 3, while the 
corresponding web version is shown in Appendix 4. The four items of the ICIQ-UI SF 
(the three first are sum-scored items) of the ICIQ-UI SF are: 
Item [1] “How often do you leak urine?” (Tick one box) [Scores 0-5] 
0 “Never” 
1 “About once a week or less often” 
2 “Two or three times a week” 
3 “About once a day” 
4 “Several times a day” 
5 “All the time” 
Item [2] “How much urine do you usually leak (whether you wear protection or 
not)?” (Tick one box) [Scores 0, 2, 4, or 6] 
0 “None” 
2 “A small amount” 
4 “A moderate amount” 
6 “A large amount” 
Item [3] “Overall, how much does leaking urine interfere with your everyday life?” 
(Please ring a number between 0 (not at all) and 10 (a great deal) [Scores 0-10]. 
As it is presented in the original questionnaire, this is a eleven-point ordinal 
scale more than a visual analogue scale, ranging from 0 “Not at all” to 10 “A 
great deal,” as there is no continuous line. 
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Item [4] “When do you leak urine?” (Please tick all that apply to you). [Unscored]. 
This item covers different aspects of UI: no UI (#1), UUI (#2), SUI (#3, #5 and 
#6), NE (#4), IUI (#7) and CUI (#8). 
The answers to the first three items result in a sum score, ranging from a 
minimum score of 0 (“no UI”), to a maximum score of 21. Preliminary cut-off scores 
were set to 0= “no UI” and ≥1= “UI.” The first two items are “objective” measures, 
summing up to a range of 0 to 11, while the third item is a “subjective” measure 
ranging from 0 to 10. 
We used an official Norwegian language version (bokmål) of the ICIQ-UI SF 
that was translated from English (Appendix 3) by the ICI modular questionnaire study 
group. This form was incorporated into Web survey, as shown in the screen dumps in 
Appendix 4. In the web-form, items 1-3 are presented in the opposite direction 
compared to the authorised version. 
1.2.4 The ISI (Appendixes 2 and 4) 
The Incontinence Severity Index  (ISI) was developed in Professor Steinar Hunskaar’s 
research group by Hogne Sandvik for use in epidemiological surveys to identify the 
severity of urinary leakage in women with UI. The ISI is a semi-objective and 
quantitative measure, which purposely does not include a HRQoL dimension or other 
subjective perceptions of leakage as being a problem or not, and thus reflects the 
current UI definition of ”any leakage.” Due to limited power, the first study published 
in 1993 was only able to validate a simplified 3-level version of the ISI.[47] In a second 
study published in 2000, more women (n=265 with 315 pad-weighings) were 
included, and Sandvik et al. were able to demonstrate that a four-level index was just 
as valid.[48] Sandvik et al. recommended using the four-level index as it also gives a 
more balanced distribution in clinical studies. Since its introduction in 1993, the ISI 
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has been used in many different studies of UI, both epidemiological[49-63] and clinical 
studies.[64-79] The ISI has received the highest grade of recommendation by the 
committees of the 2nd and 3rd International Consultations on Incontinence.[28, 29] 
In Paper II, the 3-level Incontinence Severity Index  (ISI) developed by 
Sandvik et al.[47] was used to characterise the severity of incontinence. This index is 
calculated by multiplying the reported frequency (four levels) by the amount of 
leakage dichotomised to two levels: 
Item [1] “How often do you experience urinary leakage?” (Four levels): 
1 “Less than once a month” 
2 “One or several times a month” 
3 “One or several times a week” 
4 “Every day and/or night” 
Item [2] “How much urine do you lose each time?” (Two levels): 
1 “Drops or little” 
2 “More” 
By multiplying the scores of question [1] and [2], the resulting score is a 
multiplicative index score with values from 1 to 8. The resulting index scores 1 to 8 
points, and is further categorised into three levels: 
“Slight”  1 to 2 points 
“Moderate”  3 to 4 points 
“Severe”  6 to 8 points 
Typically, slight incontinence denotes leakage of drops a few times a month, 
moderate incontinence denotes daily leakage of drops, and severe incontinence 
denotes larger amounts at least once a week. In this development study, Sandvik et al. 
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found in 1993 that slight incontinence meant a leakage of 4 g/24 hours (95% [CI]: not 
calculated); moderate meant 17 g/24 h, and severe meant 63 g/24 h.[47] 
The 3-level ISI has later been validated against pad-weighing tests in two 
studies, one by Sandvik et al. in 2000[48] and one by Hanley et al. in 2001.[80] In their 
validation study, Sandvik et al. found that slight incontinence meant a leakage of 6 
g/24 hours (95% [CI]: 2 to 9); moderate meant 17 g/24 h (13 to 22), and severe meant 
56 g/24 h (44 to 67).[48] 
In the validation study by Hanley et al., they found that reliability and 
responsiveness of the 3-level ISI was satisfactory. They found that slight urinary 
incontinence represented a median leakage of 32 g/48 hours; moderate 29 g/48 h, and 
severe 143 g/48 h (χ2 = 14.9, P < 0.001; mean ranks 41.8, 50.2, and 80.7 
respectively).[80] 
In Paper III, the 4-level ISI was used in its original form in Norwegian 
translation. It consists of two items, defining frequency (four levels) and volume 
(three levels) of leakage.[48] The ISI is a multiplicative score based on these two items: 
Item [1] “How often do you experience urinary leakage?” (Four levels): 
1 “Less than once a month” 
2 “A few times a month” 
3 “A few times a week” 
4 “Every day and/or night” 
Item [2] “How much urine do you lose each time?” (Three levels): 
1 “Drops” 
2 “Small splashes” 
3 “More” 
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By multiplying the scores of question [1] and [2], the resulting score is a 
multiplicative index score with values from 1 to 12. This index score is then further 
categorised into four levels of incontinence severity:[48] 
“Slight”   1 and 2 points 
“Moderate”   3, 4 and 6 points 
“Severe”  8 and 9 points 
“Very severe”  12 points 
The ISI has later been scored “0” for “no incontinence” in studies where e.g. 
treatments result in patients turning from being incontinent to continent. 
The 4-level ISI has been validated against pad-weighing in two studies, the 
previously described study by Sandvik in 2000[48] (also 3-level ISI), and in a Spanish 
study in 2006.[81] 
For the 4-level ISI used in a Norwegian population, Sandvik et al. found slight 
incontinence to indicate a leakage of 6 g/24 hr (95% [CI]: 2 to 9), moderate 
incontinence 23 g/24 hr (15 to 30), severe incontinence 52 g/24 hr (38 to 65), and very 
severe incontinence 122 g/24 hr (84 to 159).[48] 
In the Spanish study, Sandvik et al. found slight incontinence in primary care 
vs. hospital care to indicate a leakage of 10 g/24 hr (95% [CI]: 2 to 17) vs. 6 g/24 hr 
(3 to 9), moderate incontinence 32 g/24 hr (17 to 47) vs. 44 g/24 hr (24 to 63), severe 
incontinence 100 g/24 hr (49 to 151) vs. 102 g/24 hr (70 to 134), and very severe 
incontinence 223 g/24 hr (-8 to 453) vs. 193 g/24 hr (124 to 261), respectively. 
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1.3 From paper to Web-based epidemiological research 
1.3.1 Postal methods 
Many researchers have experienced that conducting postal surveys for 
epidemiological research is costly and time-consuming, with many demanding 
manual phases of work. The manual processes have been eased since the days of the 
classic paperweight, after e.g. the introduction of a Pitney Bowes machine for folding 
forms and feeding them into envelopes at our office. The three photos depict a letter 
weight (Photo 1), a paper folding and enveloping machine (Photo 2), and 
questionnaires folded, enveloped and stamped, ready to be delivered by the post office 
(Photo 3). 
   
(Photo 1: Atle Klovning)           (Photo 2: Atle Klovning)                    (Photo 3: Atle Klovning) 
 
Since the manual punching and coding of data may often lead to erroneous 
data entry, and in order to compensate for most of these manual efforts, companies 
enabling an automatisation of these processes from defining a layout of the 
questionnaire, producing the final form, merging it with an address list, printing, 
enveloping, stamping and posting these forms have solved some of the researchers’ 
requirements. When the forms are returned, they may be OCR-read and entered 
directly into a database. 
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1.3.2 The Internet and the World Wide Web 
The English scientist Tim Berners-Lee invented the World Wide Web in 1989, and 
was knighted in the UK for this achievement in 2004. It is important to distinguish 
between the Internet and the World Wide Web (WWW). While the Internet is the 
hardware and software technologies that connect the physical computers, the World 
Wide Web is one of the many services offered on the Internet; other services are e.g. 
e-mail, chat, online games and video. Today, the community-enabling software 
Facebook, with its over 500 million users might represent a new research arena to be 
explored. As an example of this, I was recently asked to review a paper that uses 
Facebook as an arena for qualitative research, and I expect that many studies using 
such community Webs will be performed in the future, and to enable new arenas for 
recruitment to Web-based studies, for both quantitative and qualitative research 
methods. 
1.3.3 Web-based research 
Searching Medline February 2010 with the term ”World Wide Web”, I retrieved 
40,717 articles, the earliest from 1994. Using the search term “Internet”, I retrieved 
39,765 articles. Using the Boolean operator “OR” between the two terms in order to 
define any complementary set of papers, yields 40,717 papers. Although, the defined 
MeSH-term is “Internet,” this simple search shows that the phrase search “World 
Wide Web” is a more complete search term. By browsing through the list of papers 
retrieved, the first years of these papers mainly covered IT-communication and 
teaching/learning, thereafter imaging and telemedicine. 
The first paper I found relevant for this thesis is one on ”Health status 
assessment via the World Wide Web,” published in 1996.[82] This study lasted one 
year, and collected data from 4,876 individuals on the Web using the RAND 36-item 
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multiple-choice questionnaire. The authors were optimistic and concluded that “the 
use of Web technology to administer patient surveys could dramatically lower the cost 
of performing both randomised clinical investigations and routine outcomes 
monitoring. As a result, the WWW may play an important role in advancing health 
services research and outcomes-based patient care.” 
Eysenbach cited this paper in a Letter to the BMJ, stating: “Obviously, the 
Web community is not a representative sample of the whole population, and results 
obtained with questionnaires on the WWW are biased towards self-selection; thus 
they must be interpreted with care and verified in an unbiased population.”[83] 
The largest Web-based epidemiological study I found in my literature search is 
a Swedish follow-up study of 96,000 women born between 1943 and 1962 (then aged 
30-49 years) residing in the Uppsala region, and who were invited to fill in a posted 
paper form in 1991/92.[84] The overall response rate was low, 51% (49,248 women). 
Of the original 96,000 women, 47,859 (50%) were recruited to answer questions 
about smoking, body size and shape, use of oral contraceptives and their reproductive 
history, altogether approximately 70 items to answer. In section 6.2 of her thesis,[85] 
Ekman points out that the questionnaire was large, with 90- not 70 items, and took 1½ 
hours to fill in. 
The Web-based follow-up study was launched in February/March 2003, and 
invited 47,859 women to answer a web-based questionnaire only. The response rate to 
this study was 33% (15,922 women). The 31,937 non-responders were randomised to 
5 different response modes depending on whether they had provided their e-mail 
address or not. 
Among the 30,880 women without an e-mail address, 4,974 received a postal 
reminder with a paper questionnaire or optional Web-form (Group 1.1), 25,906 
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received a postal reminder only with the Web option (Group 1.2). The 1,057 who had 
provided their e-mail addresses were randomised into 3 groups. Group 1.3 received a 
postal reminder with either a paper or a Web questionnaire, Group 1.4 received an 
email with a login to the Web questionnaire, while Group 1.5 received an email with a 
direct link to the Web questionnaire, not requiring login. 
The overall response rate after this first reminder increased from 33% to 45%. 
Of these additional 12%, 3,476 (61%) used the Web option. But, when given the 
option of paper versus Web, the women preferred paper. In Group 1.1, only 139 of 
2,149 (6%) chose Web, and in Group 1.3 20 of 191 (11%) did so. 
After the second reminder, the overall response rate rose from 45% to 72%. 
The women were either randomised to a postal reminder with a paper questionnaire 
(25, 145 women) or e-mail reminder with login (1,135 women). Web responses 
accounted for only 198 of these 26,280 (0.8%) second reminder responders. 
In total, after 2 reminders, 41% responded to the Web questionnaire, while 
31% responded to the paper questionnaire. Analysing response rates to a more 
profound extent, they found that the Web-, paper- and non-responders respectively did 
not differ significantly in age, physical activity levels, and BMI. The responders 
answering either the Web or paper questionnaires had a higher level of education and 
income and a lower level of smoking than non-responders. The RRs for the 
association between different sociodemographic variables showed that using the Web 
did not introduce any important issues compared to using traditional, postal methods. 
The authors found no mode effect. The bias associated with collecting information 
using Web questionnaires were not greater than that caused by paper questionnaires. 
This paper is one of the papers in Alexandra Ekman’s thesis.[85] She argued that 
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Sweden is well situated for Web-based surveys and epidemiological studies because 
of the massive outreach of the Internet. 
Summing up, this study showed that a Web-only solution would only give a 
response rate of 41%, and only by having the option to fill in a paper version would 
the overall response rate be 72%. However, it should be noted that the response rate in 
1992 was only 51%. The follow-up study showed that a combination of different 
response modes gave the highest response rate. 
Representation issues and biases 
Couper published three useful papers on the different issues of importance for 
researchers using the Web for research- a review in 2000,[86] a study on designing 
Web-based surveys,[87] and a paper on representativity issues.[88] 
In the paper on ”Web surveys: A review of issues and approaches,”[86] Couper 
discusses the pros and cons of the Web-survey methods. Three biases are important: 
coverage and sampling bias, nonresponse bias and measurement bias. Nonresponse 
bias occurs when not all people included in a sample are willing to complete a survey, 
and measurement bias arises when responses deviate from their true values. This 
could be because of lack of motivation, comprehension problems, poor wording or 
design. Using telephone or an interviewer gives a possibility to explain and clarify the 
questions. Coverage and sampling bias occurs when one does not reach the 
appropriate target population. 
The paper also discusses different modes of recruitment that might be used to 
increase participation rates in Web-based studies. The table below is from this paper, 
and illustrates the main types of Web surveys. Study II in this thesis is an unrestricted 
self-selected survey. 
 28 
 
In another paper, the same Couper discusses these issues of representation in eHealth 
research; with a focus on Web-surveys.[88] In short, Couper urges caution, particularly 
in replacing existing research methods with Web-based methods only. 
Producing Web-based forms 
Couper also investigated different modes of designing and presenting a survey on the 
Web.[87] This Web survey was designed to study the use of a progress indicator or not, 
multiple-item screens versus single-item screens, and radio buttons versus entry 
boxes. Couper found that entry boxes were easier to avoid answering, but rather than 
arguing for one certain approach, he suggested that a more tailored response should be 
applied. Couper found only marginal evidence for the hypothesis that a progress 
indicator reduces respondent abandonments. He found faster completion times and 
less missing data for multiple-item screens. 
In a randomised testing of alternative survey formats amongst 4,208 
anonymous volunteers over three months on the WWW, Bell et al. found that the 
matrix format speeded up the completion time of the SF-36, compared to a list 
format.[89] 
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Another useful guide, is the one published by Birnbaum on how to perform 
Web-based research.[90] In this overview, he describes the major issues concerning 
designing, programming, and executing of Web-based research, and discusses the 
different related pitfalls. 
One way of reducing nonresponse bias might be to use registry-based emails, 
as in alternative 7 in the previous table. In a systematic review of 17 Internet-based 
surveys of health professionals, Braithwaite et al. finds that response rates varied from 
9 to 94% in 12 studies,[91] and discussed the issue of problematic external validity of 
findings from Web-based studies. 
Demands on Web survey tools 
Bälters et al. addressed the requirements of tools for Web-based epidemiological 
research.[92, 93] In the first paper published in European Journal of Epidemiology in 
2005,[92] they argued in favour of Web-based epidemiology: 
“Data collection in epidemiological studies is to a large extent made by printed 
questionnaires, telephone interviews, face-to-face interviews, or a combination 
of these methods. These methods are costly and time consuming. The main cost 
in using printed questionnaires comes from completing missing or unrealistic 
answers by phone interviews, and transferring the answers to computer readable 
format. Furthermore, the time period between the first distribution of a 
questionnaire and first statistical analyses may be long, maybe months or even 
years.” 
They pointed out that Web-based surveys have the potential of reducing these 
problems significantly, and two main advantages of Web questionnaires compared to 
traditional printed questionnaires are the immediate control of answers, and instant 
electronic storage. 
In a subsequent brief report in Epidemiology, they present the following 
supportive arguments for Web-based epidemiology:[93] 
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“Web questionnaires can be used for research purposes in population-based 
settings in which Internet access is high, although we found that the initial 
response rate was lower than for the traditional printed questionnaire. In 
comparison, the willingness to answer a second questionnaire was higher when 
using a Web questionnaire instead of a printed questionnaire. Personalised 
feedback in the Web questionnaire further increased the compliance rate for a 
second questionnaire. Total response rates for the second part of the 
questionnaire were similar for the printed and the Web questionnaires.” 
Security issues 
On the other side, Bälter et al. argue that the fear of entering sensitive data could 
reduce the number of respondents. [92] Already, the Web has been used to collecting 
sensitive data: information about drug dealing, drug and alcohol use, and sex habits. It 
seems that on the Web, people are even willing to expose themselves to poker and 
pornography, and as a consequence of this are at a great risk of exposing themselves 
and their computers to devastating security attacks. There have been performed 
several Web studies on perceived stigmatising conditions - like vaginal pain,[94] 
depression,[95] vestibular pain,[96] and illicit substance abuse,[97, 98] assuming that the 
”anonymous” study setting might ease people in exposing taboos. UI too, has been 
regarded as a stigmatizing disorder, and faecal incontinence an even more 
burdensome condition. It is a major concern that people are willing to share any kind 
of information on the Internet, thinking they are in the safe realms of their private 
homes, while it also may provide new and useful research arenas, as long as we can 
be sure that researchers, Web survey producers and ethical committees share a 
responsibility in taking care of the integrity and privacy of the WWW responders. 
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2 Aims of the two studies in this thesis 
The aims of this thesis were to validate scored questionnaires to be used in clinical 
practice and epidemiological research on urinary incontinence (UI). 
2.1 Study I 
- To validate a scored questionnaire, the Detrusor Instability Score (DIS) 
(Paper I) 
2.2 Study II 
- To analyse how Web-based recruitment performs compared to postal surveys 
(Paper II) 
- To validate the International Consultation on Incontinence Questionnaire - 
Urinary Incontinence Short Form (ICIQ-UI SF) against the Incontinence 
Severity Index (ISI) (Paper III) 
- To construct a severity scale for the ICIQ-UI SF (Paper III) 
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3 Materials and Methods 
3.1 Participants 
3.1.1 Study I (Paper I) 
The outpatient clinic 
The findings in this study were based on 250 consecutively included patients at an 
outpatient clinic at the University Hospital in Trondheim, Norway. More detailed 
information about this clinic has been published in a Norwegian paper with English 
abstract.[99] In 1988 this clinic was awarded “Det nytter prisen” by the Norwegian 
government for its outstanding service, a prize for the most beneficial health service 
in 1988. 
A urotherapist used a structured questionnaire to record the history (Appendix 
1) and gathered other relevant information prior to the examination by a specialist in 
urogynaecology. The mean age of the women that were included (± s.e.m.) was 49 
years (± l). Of the women, 96 of them (42%) had been incontinent for 10 years or 
more. Urodynamic investigations of these women revealed stress incontinence in 
58%, sensory urgency in 19%, motor urgency in 21% and mixed incontinence in 32%. 
Using a 3-level severity index, we found that 7% had slight, 25% moderate, and 68% 
severe urinary incontinence. 
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3.1.2 Study II (Paper II and III) 
Web-based recruitment 
We used the Web (see Appendix 4) to invite a convenience sample of women to join a 
women’s health study by self-selected participation, focusing on women’s general 
health. 
Female users of major Norwegian Internet sites were asked to join the study 
by three different routes: a general health Web site (NettDoktor.no), the health section 
of a general-purpose Web portal (StartSiden.no), and the newspaper Web site of 
Verdens Gang (VG.no). NettDoktor was, at that time, the Norwegian part of Europe’s 
largest health Web site, StartSiden was Norway’s largest Web portal, and VG.no, 
Norway’s largest Web-based newspaper. At the first two of these Web sites we used 
fixed placed banners containing the logo of the University of Bergen, whereas at 
VG.no the study was linked to NettDoktor by a link in an interview in VG.no 
(Appendix 4). The three investigators were named on the introductory page of the 
Web questionnaire. The study was anonymous, and informed consent was not 
considered necessary, as the study collected no personal information and participation 
was voluntary. 
Between February 23, 2002 and April 22, 2002, women accessing the 
NettDoktor Web site were recruited by a banner with the text: “Join the large 
women’s health study at the University of Bergen” on the front page of 
www.NettDoktor.no (NettDoktor). Between April 25, 2002 and August 20, 2002, 
women were able to access our study by means of StartSiden (www.startsiden.no), 
where we used the text “UiB/Join the women’s health study” on the front page of the 
health section (http:// www.startsiden.no/helse/). The VG på Nett (www.vg.no) 
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interviewed me about urinary tract disorders, incorporating a direct link to the study in 
the Web text, easily accessible in the period from March 4, 2002 to March 6, 2002. 
Altogether 1,812 female Web users were recruited, and 343 of them were sub-
branched into two incontinence questionnaires by answering “Yes” to a single 
question on whether they had “Any leakage of urine” (Appendix 4). Those who 
answered “No” were not entered into this part of the questionnaire; one of the features 
Web-based forms enable. 
Split-half sampling for scaling the ICIQ-UI SF 
We used split-half sampling for developing and validating the severity grading of the 
ICIQ-UI SF.[100] The random functions in SPSS were used to extract a random half of 
the 343 women with UI, yielding a development sample (n=171) and a validation 
sample (n=172). The respondents in the first sample were used to develop the scale 
for the ICIQ-UI SF, while the remaining respondent sample was used to validate the 
severity scaling of the ICIQ-UI SF. 
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3.2 Methods 
3.2.1 Study I 
The structured study questionnaire 
The complete study questionnaire is shown in Appendix 1. It is a multiple-choice 
questionnaire, incorporating the 10-item DIS.[101] It consists of six sections with a 
total of 50 items, covering the gynaecological history, voiding history divided into the 
storage phase (sensation, detrusor activity, SUI), the emptying phase, and the severity 
of the UI. Based on this structured questionnaire, the urotherapist recorded the 
diagnosis. The DIS was not calculated. After the urodynamic investigations, the 
urodynamic diagnosis and the gynaecologist’s final diagnoses were separately 
recorded. The urotherapist and the gynaecologist were blinded to each other’s 
diagnosis and to the DIS. The DIS (Kauppila score) was independently calculated by 
the authors AK and SH of Paper I after the study was over, and the forms had been 
sent to the University of Bergen, Norway. 
The DIS 
Kauppila et al. developed this sum-score and published it in 1982. They had observed 
that the major cause of failure in the surgical treatment of stress urinary incontinence 
(SUI) in women was occult detrusor instability. In order to detect the degree of 
detrusor instability, urological histories were standardised by scoring the replies to ten 
specific questions with 0 (indicative of SUI), 1 or 2 (slightly and markedly indicative 
of detrusor instability, respectively). The sum of the scores was termed the "detrusor 
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instability score" (DIS). In the original paper they proposed a cut-off level at 7,[101] 
and chose a cut-off level at 5 when the DIS was validated this in a subsequent 
paper.[102] The aim of our study was to validate this cut-off level in an outpatient 
setting. Table 1 on page 138 of the development study by Kauppila et al. shows the 
different items of the DIS.[101] Note the incomplete wording of each question. 
 
In the development study,[101] the DIS was calculated for 134 patients both 
preoperatively and 2 years after operation, and 112 of these women were also 
evaluated by bead-chain urethrocystography (UCG) before operation. They found a 
10% failure rate among the 72 patients with a DIS of 0-7, which they defined to be 
caused exclusively or nearly exclusively by detrusor instability, significantly less than 
the 32% failure rate in the 62 women with a DIS of 8-16, which they defined to be 
SUI complicated by marked detrusor instability. The 38% failure rate in 47 women of 
peri- or post-menopausal age and having a DIS of 8-16 was higher than the 10% in 
the remaining 87 women. 
Further, they found that there was an increased risk of failure in patients who 
had a DIS of 8-16 combined with either a urethral inclination angle ≤ 80 degrees 
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(46% failure rate in 28 women) or a posterior urethrovesical angle ≤ 160 degree (43% 
failure rate in 30 women) in lateral bead-chain UCG during straining. As a measure of 
responsiveness, they observed that the mean DIS decreased after successful surgery, 
but remained constant in cases of failure. The scored urological questionnaire seemed 
to facilitate the detection of patients with detrusor instability. This was potentiated by 
lateral bead-chain UCG findings which indicated a low motility of the proximal 
urethra or bladder neck.[101] The authors concluded that in patients with a DIS of 0-5 
and a positive Marshall test operation was indicated, whereas these patients should be 
treated conservatively if the Marshall test was negative. Patients with DIS 6-20 should 
undergo UDI prior to surgery for SUI. 
The DIS has been used in several settings, like books,[103] studies on the 
agreement of anamnestic data by Voigt,[104] Kujansuu,[102] and in the preparation of 
Swedish guidelines.[105] 
Urodynamics 
According to Rosier et al. the conventional view of urodynamics was a series of more 
or less agreed-upon clinical tests consisting of e.g. flow- and pressure-flow studies, 
filling cystometry and/or assessment of the urethral closure function. [106] Also, 
Dmochowski argued that although UDI is a demanding procedure, it remains the only 
functional evaluation of bladder and urethral activity that can segregate detrusor and 
urethral contributions to incontinence and voiding function.[107] 
In our study, pressure measurements were performed using a fibre-tip sensor 
connected to the Laborie system 2 000 (Camtech Ltd.). Simultaneously, 
urethrocystometry was done in a semi-prone position with temperated water at a 
filling speed of 25 ml/min. The volume at first sensation of micturition was measured. 
Urgency, bladder capacity, and uninhibited detrusor contractions in the filling phase 
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were registered. In patients with GSI anamnestically, a normal micturition list, and 
normal sensibility in the filling phase, bladder filling was restricted to 300ml. Urethral 
pressure-profile measurements in the semi-prone position were done at the above-
mentioned capacity with the same sensor. With an automatic withdrawal unit the 
catheter was retrieved from the urethra at a speed of 2 mm/sec. We registered three 
resting profiles and three cough profiles. Functional urethral length, maximum 
urethral pressure and maximum closure pressure were calculated as a mean of these 
three. The differential pressure was registered simultaneously with the cough profiles. 
Finally, flowmetry was done with the patient sitting. 
For further explanation of terms, consult the most recent IUGA/ICS join 
report.[17] 
Establishing the gold standard 
Based on the descriptions of gold standards, the one that was used in Study I, can be 
described as en expert opinion diagnosis, with or without prior UDI. 
In Appendix 1, a guide for filling in the forms is provided. In short, the 
urotherapist filled in the structured questionnaire, i.e. the three pages of the form that 
were stapled, filling in only one type of incontinence, but had the option to fill in 
other diagnoses in the “other” four fields. The urotherapist did not calculate the DIS 
(Kauppila score). 
Page 4 of the questionnaire was loose-leafed and followed the patient’s 
medical record. The gynaecologist had no knowledge neither of the structured study 
questionnaire, nor the diagnosis the urotherapist had set, nor the DIS. The 
gynaecologist recorded a urodynamic diagnosis (several options permitted) and the 
final clinical diagnosis based on the UDI and an extensive gynaecological assessment. 
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The gold standard chosen in this study was the gynaecologist’s expert opinion based 
on UDI. 
Sensitivity, specificity, PPV and NPV and accuracy 
The calculations for the test characteristics sensitivity, specificity, PPV and NPV and 
accuracy were performed in accordance with the definitions used in the book 
“Clinical Epidemiology.”[108] 
ROC 
ROC-curves are actually a plot of the true positive rate (sensitivity) on the Y-axis 
against the false positive rate on the X-axis (1-specificity), according to Sackett’s 
book on p. 117.[108] It is also possible to convert the data to odds ratios to enable 
pooling of data for a meta-analysis.[109] A very useful Web site explaining the ROC is 
the one by Steve Simon.[110] We chose to use ROC-curves because they were thought 
to be the best way of illustrating test characteristics.  
3.2.2 Study II 
The WEB-EPI UI 
All screen dumps of the Web-based questionnaire are shown in Appendix 4. The 
banners or links led to a short introductory page presenting the logo of the University 
of Bergen and our department. The questionnaire was titled “Women’s Health Study 
2002.” The introductory text read: 
“At Section for General Practice at the University of Bergen we have 
investigated several female health disorders for many years. Now we wish to use 
the Internet to conduct a new study. All entries will be anonymous, and the data 
collected will be used for research purposes. We hope you would like to 
participate in this study. This will be done by answering a few questions, taking 
only a couple of minutes. If you do not want to enrol, simply click your way out. 
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Click ‘Next Page’ to continue, and ‘Clear’ to delete all. Best wishes, AK 
(Researcher), HS (Researcher), SH (Professor).” 
Page 2 of the study presented six items (age, gender, menarche, menopause, pregnant, 
number of children). Page 3 presented six more items (number of voidings per 24 
hours, night-time voidings, urinary tract infections, completeness of bladder 
emptying, urgency, urinary leakage). This last item was the only branching item in the 
entry form. It was formulated “Do you have urinary leakage?” (“Yes” or “No”), and 
clicking here was the only mandatory item to be entered. “No” directed the 
respondent to the exit page, where the respondent could choose between “Finish” and 
“Clear” in English language. “Yes” to this question defined the respondent as having 
UI, consequently branching the respondent into two validated questionnaires, the ISI 
as items number 2 and 3 of the EPINCONT questionnaire on page 4 (10 items), and 
the ICIQ-UI SF on page 5 (four items). Clicking “Next Page” or “Clear” then led to 
the exit page, with the choice between “Finish” or “Clear” in English language. After 
the exit page, the users were forwarded to a Web page on UI at NettDoktor. The 
respondents were not promised any score or feedback, and no kinds of incentives 
were offered. We had no initial contact with potential participants. Respondents 
stating they had no UI had to go through four Web pages, whereas those stating they 
had UI had to go through a total of six Web pages. Some of these pages were larger 
than normal screen resolution size, and had to be scrolled. All navigation buttons were 
non-modifiable and in English language. There were no “Back” buttons, but only 
“Next Page” or “Clear” on each page. Users were not provided a summary of their 
responses before the results were submitted. 
  43 
Terminology 
The terminology used in the published papers follow the ICS definitions as of 
2002.[23] 
The survey software 
The survey was performed using the client-side software Inquisite (Inquisite Inc., 
Austin, TX, USA), and data were deployed to a database at a Web hotel located at 
UNI⋅C, the Danish IT centre for education and research. We used no passwords or 
login procedures. Colleagues piloted the usability and technical functionality of the 
survey before it was fielded. Log files were checked; they contained no person 
identification items, e-mail addresses, IP-addresses, or cookies. Neither the 
participation rate, nor the view rate, nor the completion rates were determined. No 
check was possible to prevent users accessing the survey several times, as we did not 
use cookies, collect IP addresses, or use login forms. The time stamping of data entry 
was manually checked in the final database. Although all data were time stamped, 
there was no track of the length of time used to fill in the form. 
Confidence interval analysis (CIA) 
All confidence intervals in Table 1 in Paper II were calculated by the Newcombe 
method for comparing independent proportions using the DOS-based software, 
CIA.[111] The CIs were calculated one by one, and the asterixes were assigned by 
comparing the confidence intervals between the EPINCONT and the WEB-EPI UI 
studies. The single asterisk (*) indicate the instances where the point estimate of one 
variable is not an element of 95% CIs of the corresponding variable, thereby 
indicating a statistically significant difference. The double asterisks (**) indicate the 
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instances where the confidence interval for the difference between the independent 
proportions does not contain zero, implying a statistically significant difference. 
Correlation strategy 
In Paper III the four levels of the ISI were plotted against the ICIQ-UI SF total sum-
score with and without the HRQoL dimension. The association between the ISI and 
ICIQ-UI SF scores was investigated by Spearman’s rank correlation coefficient 
(rho),[112] as this correlation is used for ordinal variables. 
Determination of unweighted Kappa values 
Kappa values were calculated using the SPSS on 4x4 contingency tables of the 
severity (slight, moderate, severe, very severe) of UI by arbitrarily changing the 
severity intervals until maximum Kappa was obtained. 
Kappa with weighting (Lowry) 
To my knowledge, SPSS is only able to produce unweighted Kappa statistics, so in 
order to achieve the weighted Kappa statistics, the contingency tables with maximum 
unweighted Kappa values produced by SPSS were manually entered into the dynamic 
Web pages provided by Professor emeritus Lowry.[113] This could probably have been 
programmed in SPSS, but functioned well on the Web site. By entering these tables 
into the Web site, we were able to calculate Kappa scores with linear and quadratic 
weighting. 
Scaling the ICIQ-UI SF 
In order to create a scale for the ICIQ-UI SF based on the ISI as the assumed gold 
standard, we iteratively calculated the weighted Kappas for the unweighted Kappas 
that SPSS produced for the different intervals for the severity of the ICIQ-UI SF and 
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the ISI. This process might also have been programmed, but functioned well the way 
it was done manually for the development sample (n=171) described at the end of 
section 3.2.1. Accordingly, the weighted Kappas were calculated for the validation 
sample. 
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4 Summary of results 
4.1 Paper I 
Klovning A, Hunskaar S, Eriksen BC. Validity of a scored urological history in 
detecting detrusor instability in female urinary incontinence Acta Obstet Gynecol 
Scand 1996;75:941-5. 
 
Aim: 
- To validate a scored questionnaire, the Detrusor Instability Score (DIS). 
 
The mean age (s.e.m.) of the 250 women included was 49.2 years (0.9) (range 15-83). 
Mean DIS (s.e.m.) for all patients was 6.0 (0.2). Mean DIS (s.e.m.) for patients whom 
the gynaecologist classified as having GSI, mixed incontinence and pure urge 
incontinence was 5.2 (0.3), 8.0 (0.4) and 7.4 (0.5) respectively, when diagnoses were 
based on urodynamic findings alone, and 5.6 (0.3), 7.9 (0.6), and 7.6 (0.5) when 
diagnoses were based on both urodynamic and clinical assessment (the clinical 
diagnosis). We continued further evaluation with the clinical diagnosis alone, 
dichotomising the patients into those having genuine stress incontinence or not. 
We found that the proposed cut-off level for the DIS at 7 resulted in too many 
false positive findings to be useful as a preoperative tool. In 159 women (64%) having 
GSI as defined by a cut-off value for the DIS set to 7, we found that 41 of these 
women (16%) were actually given a false positive diagnosis. This could have been 
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acceptable for conservative (non-surgical) treatments in primary health care settings, 
but not for surgical treatment. On the other hand, if the cut-off level was lowered to 5 
for the DIS, 112 women (45%) would be diagnosed as having GSI, with only 20 
women (8% of 250 women) having a false positive diagnosis. The important issue 
here is whether these women, if otherwise feasible and indicated, could undergo 
continence surgery without preoperative urodynamics. Also, this cut-off level was the 
level most optimal as defined by the ROC-curve, as it was the point nearest to the 
upper left corner. 
Consequently, we concluded that a lower cut-off point than originally 
proposed was needed for the DIS to become a useful preoperative tool for continence 
surgery (DIS of 5). 
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4.2 Paper II 
Klovning A, Sandvik H, Hunskaar S. Web-based survey attracted age-biased 
sample with more severe illness than paper-based survey. J Clin Epidemiol 
2009;62:1068-74. 
 
Aim: 
- To analyse how Web-based recruitment performed compared to postal surveys 
 
We recruited 988 respondents (2 months) from www.NettDoktor.no, 708 from 
www.VG.no (3 days), and 116 from www.startsiden.no (4 months), adding up to a 
total of 1,812 respondents, mean age 37 vs. 48 years, P<0.05. We excluded 36 men, 
19 respondents with missing gender information, 38 with missing age information, 99 
women below 20 years of age in order to have a sample comparable to the study 
population in the EPINCONT, and one with apparently nonsensical responses, leaving 
1,619 cases for further analysis. 
We found that the WEB-EPI UI sample was younger than the EPINCONT 
sample. The mean age (SD) for the 1,619 women included was 32 (10) years, and the 
median age was 30 years (range: 20 to 69 years) in the Web-based study. 
Corresponding figures for the EPINCONT study were: mean age 49 (17) years, and 
the participants’ age ranged from 19 to 98 years. Only 11 women (3.3%) were older 
than 60 years in the Web-based study compared with 2,396 (29%) in the EPINCONT 
study. The age group 20 to 29 and 30 to 39 years were highly overrepresented in the 
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Web study. The crude unadjusted prevalence rate (95% CI) of UI in our study was 
20% (18 to 22) (n= 325). Similarly, the crude unadjusted prevalence rate of UI in the 
EPINCONT study was 25% (24 to 25) (n= 6,876). The mean age (SD) for the 1,294 
continent women in our study was 31 (9) years, and 37 (11) years for the 325 
incontinent women, compared with 48 (17) and 53 (16) years in the EPINCONT 
study, respectively. The age-adjusted prevalence of UI in the WEB-EPI UI population 
higher or similar to, the EPINCONT study for all ages we have reliable data on. 
We studied age-adjusted characteristics of the condition among incontinent 
women in our study compared with data from the EPINCONT study. We found the 
following statistically significant differences: in the WEB-EPI UI sample, we found 
fewer women with slight UI in all age groups, and more women with moderate (30 to 
39 and 50 to 59-year age groups) and severe UI (20 to 29, 30 to 39 and 40 to 49-year 
age groups).5 We found fewer women with stress UI (20 to 29 and 30 to 39-year age 
groups), more women with urge UI in the two youngest age groups, and more with 
mixed UI in the 30-39-year age group. 
We concluded that we recruited a younger population with more severe UI 
than the EPINCONT study. Web-based approaches seem to be less appropriate than 
postal methods for studies of conditions with higher prevalence in the elderly 
population; and UI is such a condition. 
                                                 
5 NB! The ”severe” group was erroneously described as 30 to 39, 40 to 49 and 50 to 
59 in Paper II. 
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4.3 Paper III 
Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires 
for assessing the severity of urinary incontinence: The ICIQ-UI SF versus the 
Incontinence Severity Index. Neurourol Urodyn 2009;28:411-15. 
 
Aims: 
- To validate the International Consultation on Incontinence Questionnaire - Urinary 
Incontinence Short Form (ICIQ-UI SF) versus the Incontinence Severity Index (ISI), 
- To construct a severity scale for the ICIQ-UI SF. 
 
We performed a Web-based comparison of two questionnaires assessing the severity 
of UI, the ICIQ-UI SF vs. the ISI, using the ISI as the gold standard. Altogether 1,812 
women completed the entry questionnaire of the WEB-EPI UI. Of these, 343 (19%) 
declared having any involuntary urinary leakage, and were subsequently branched 
into the urinary incontinence arm of the study. Mean age (SD) for these women was 
36.5 (11) years and the distribution of stress, urge, mixed and other incontinence was 
41%, 17%, 39%, and 3%, respectively. We found no statistically significant 
differences between corresponding variables from the three different Web sites. All 
data were therefore analyzed as a whole. 
Responses (n= 343) to the ISI item I assessing frequency were 14% “less than 
once a month,” 34% “a few times a month,” 34% “a few times a week,” and 18% 
“every day and/ or night.” Responses to the ISI item II assessing volume were 54% 
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“drops,” 42% “small splashes,” and 4% “more.” The mean ISI score (SD) was 1.82 
(0.70). The mean (SD) ICIQ-UI SF total score was 7.4 (3.6) with, and 4.3 (1.7) 
without the HRQoL item. 
There were strong correlations between the four-level ISI and ICIQ-UI SF 
scores with versus without the HRQoL item; Spearman’s rho was 0.62, P < 0.01 
versus 0.71, P < 0.01. By adjusting the intervals for the ICIQ-UI SF total score for the 
study subjects in the first scale development file to obtain maximum agreement with 
the four levels of the ISI, we could define the following intervals for the ICIQ-UI SF 
(n = 171): slight (1-5), moderate (6-12), severe (13-18), and very severe (19-21) 
(Kappa with quadratic weighting = 0.61). Similarly, for the ICIQ-UI SF without the 
HRQoL item, we could define the following levels: slight (1-3), moderate (4-5), 
severe (6-9), and very severe (10-11), (Kappa with quadratic weighting = 0.71). 
Applying these intervals to the second sample (n = 172) in order to validate our 
findings, Kappa with quadratic weighting for ICIQ-UI SF with and without the 
HRQoL item was 0.61 and 0.74, respectively. 
Our findings suggest that the ICIQ-UI SF may be divided into the following 
four severity categories: slight (1-5), moderate (6-12), severe (13-18) and very severe 
(19-21) UI. Disregarding the HRQoL-item, the four severity grades would be slight 
(1-3), moderate (4-5), severe (6-9) and very severe (10-11). 
  53 
5 Discussion of methods 
5.1 Study I (Paper I) 
5.1.1 Strengths 
Triple blinding 
The triple blinding used in this study is one of its strengths, and is described in greater 
detail in section 2.2.1 “Establishing a gold standard.” Although the DIS was 
incorporated into the structured questionnaire the urotherapist used; the urotherapist 
had no knowledge of it, and it was not a part of the gynaecologist’s work-up either, 
enabling us to avoid incorporation bias. The urotherapist had no knowledge of the 
final diagnosis set by the urogynaecologist, and vice versa. In addition, independent 
researchers analyzed the collected data;6 the urotherapist or the gynaecologist did not 
perform any coding of data or analysis initially. By this approach, all effort possible 
was taken to assure an unbiased, blinded analysis of the data. By triple blinding, we 
secured the study against work-up bias and diagnostic review bias. 
The gold standard 
Defining the gold standard is important, and should, if feasible, reflect standard 
clinical practice. Sometimes gold standard methods may include invasive methods 
that may be stressful for the patient like e.g. UDIs. More seldom, gold standard 
                                                 
6 Atle Klovning and Steinar Hunskaar 
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methods may even be harmful methods; e.g. using contrast media may result in 
anaphylaxis. The gold standard chosen was an “expert opinion,” based on an 
extensive clinical assessment and urodynamic findings, reflecting secondary care 
practice as it is, which is important for the external validity of our findings. In Study 
I, we actually had the choice between two gold standards; either the UDIs alone, or 
the “extensive assessment” or “expert opinion” as they often are termed. In our study, 
we chose the “expert opinion” method based on the UDI, voiding diaries etc. Neither 
of them included the structured questionnaire, administered by the urotherapist, nor 
the DIS. We refer to our gold standard as the “expert opinion,” which is often the 
preferred termed in systematic reviews. 
Spectrum bias 
It is important to consider whether or not the full spectrum of UI had been examined. 
In Study I, all women had some other kind of UI due to the fact that they were all 
referred to the specialist clinic for assessment, and they reported different levels of 
severity. Also, one of the aims of the work-up at the clinic was to assess co-morbid 
DI, as DI was thought to lead to surgical treatment failure. As we pointed out in 
Paper I, those who did not have GSI had other types of UI. 
5.1.2 Limitations 
Lack of power calculation 
The number of patients included was 250; a large number for a clinical study at the 
time it was conducted; and probably large enough to ensure statistical power, although 
this should have been assessed by a pre-study power calculation, using e.g. 
nomograms or area-under-the-curve (AUC) assumptions.[114-116] 
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For example, if we anticipate achieving an AUC = 0.8 to define the DIS as a 
useful tool, we could have calculated the sample size needed. Regrettably, this was 
not done for Study I, and as a rule of the thumb should not be performed post-hoc. 
For the sake of scientific discussion as part of writing this thesis, I have performed 
this power calculation post-hoc below. 
Power calculation according to Flahault et al.[114] 
Given that we wanted to offer surgical treatment to patients scoring 0-5 for the DIS, 
we should have calculated the number of study subjects needed in the study. For a 
crude, unadjusted prevalence of 45% (see 4.4, Table 2), looking for a SpPin with a 
specificity ≥80%, so that a positive test (DIS 0-5) would rule in the women for 
surgical treatment without prior UDI, and accepting a lower CI no less than 65% with 
a 95% probability, the number of cases (Ncases) needed would be 98 according to 
Flahault’s nomogram.[114] The number of controls (Ncontrols) needed in the study would 
be calculated as Ncases·((1-prevalence)/prevalence) = 98·((100-45)/55) = 120. The total 
number of patients needed would thus be 98 + 120 = 218. In Study I, 250 patients 
were recruited, which is satisfactory, considering that a 20% loss to follow-up is 
usually accepted. 
Although we did not calculate the 95% CIs for sensitivity and specificity, this 
has been done later on in a systematic review by Martin et al.[117] Based on the 
numbers in Paper I, the sensitivity (95% CI) and specificity (95% CI) were 0.60 (0.52 
to 0.68) and 0.77 (0.67 to 0.85), respectively, so that our assumption of a CI ≥0.65 is 
catered for. 
Carley et al.[116] and Jones et al.[115] have also published relevant 
methodological papers to assist researchers in determining power calculations for 
diagnostic studies. 
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Estimation of number of patients not needing preoperative UDI 
For many invasive diagnostic procedures, the probability of having methods that use 
invasive procedures are often assumed to be gold standard methods. For example, all 
procedures sparing gastroscopy are highly welcomed. For UI, the same assumptions 
are valid- procedures that make it possible to spare invasive and costly procedures like 
UDI are just as welcome. We were able to estimate the number of patients that did not 
need to undergo preoperative urodynamic investigations in Study I; 8% had DI when 
the DIS was set to 0-5.  We were not able to select exactly who these patients were, 
though. 
Phrasing of items in the questionnaire 
For sake of clarity for non-Norwegian readers, I have constructed Table 1 to show the 
minor differences in wordings between the study questionnaire and the wording of the 
DIS as in the paper published by Kauppila in 1982:[101] 
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Table 1. This table shows the wording of the DIS as in the paper published by 
Kauppila in 1982.[101] These questions are not fully formulated in the DIS. The 
equivalent Norwegian formulation as it occurs in the questionnaire is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Table 1 it is obvious that the wording of the 10 items of the DIS is up to the 
researchers to formulate, thus making it difficult to cross-validate different studies 
using the DIS. It may be that the Finnish researchers meant that these questions were 
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to be formulated in their own languages by health personnel and researchers using 
them, so that the precise wording was not necessary, contrary to the PRO-
questionnaires, where the exact wording is vital. Since the DIS questions are not fully 
worded, this is problematic with respect to content validity.[25] 
It is problematic that there originally were three options to item 7 of the DIS: 
“No,” “Mild,” and “Strong,” while our version only used two options: “Yes” or “No.” 
The recoding in SPSS we used for item 7 was like this (from my disk copy dated 
30JAN1995): 
RECODE SP23 (1=2) (2=0) into KAUP07. 
FORMATS KAUP07 (N2). 
VARIABLE LABELS KAUP07 'Får du sterkt behov for å tømme blæra '+ 
'når du er nervøs eller stresset?'. 
VALUE LABELS KAUP07 
0 'Nei' 
2 'Ja'. 
Missing values KAUP07 (9). 
The coding is correct as the “Yes” (2 points) or “No” (0 points) are scored reversely 
in our questionnaire compared to the DIS, but we loose the ability to grade “Mild” or 
“Strong” as options (1 or 2 points). To clarify this, our study assigned 0 or 2 points to 
item 7 of the DIS, which originally had 0, 1 or 2 points. 
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5.2 Study II (Paper II) 
5.2.1 Strengths 
The gold standard 
One of the strengths of Paper II is that we were able to compare our results with 
results from a large epidemiological study on UI, the EPINCONT study, using the 
results from the EPINCONT as a gold standard. Although postal surveys have their 
own methodological problems, web-based surveys introduce others. 
Our study could not document whether we might get higher response rates 
from the younger population than when using postal surveys. The largest web-based 
study we found in our literature search (n=47,859 women) concluded that the bias 
associated with collecting information using web questionnaires was not greater than 
that caused by paper questionnaires. This finding was based on a stronger design than 
we used in our study, as they randomised respondents to either a postal or web-based 
questionnaire, or a combination, thus being in greater control of bias. The authors 
concluded that web-based questionnaires may be a feasible tool for data collection in 
large population-based epidemiological studies in Sweden.[84] 
Newcombe’s method for comparing proportions and differences between 
proportions 
Comparative analysis of results of the corresponding variables used in the WEB-EPI 
UI and the EPINCONT studies was done by calculating the 95% CIs with the CIA 
software,[1] using the Newcombe method for comparing independent proportions. 
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Single asterisks (*) were placed in Table 1 of Paper II to mark where the point 
estimate of one variable was not an element of the 95% CI of the corresponding 
variable, thus indicating a statistically significant difference. Double asterisks (**) 
were placed to mark where the 95% CI for the difference between the independent 
proportions did not contain zero, indicating a statistically significant difference.  
Although this way of comparing two independent samples is the best method 
we found, this design introduces biases and confounders. A much stronger design 
would have been to randomise the respondents to postal or web-based questionnaires. 
The strength of randomisation is that it reduces bias, as all other variables and 
confounders apart from the intervention would be evenly distributed between the 
groups. 
The study software 
We chose to use Inquisite; a commercial solution for Web research, experiencing that 
branching was one important and advantageous feature exclusive for web-based 
questionnaires, making it possible to bypass respondents on their way through the 
questionnaire. 
Today, we could have chosen even more sophisticated and powerful solutions 
like www.SurveyMonkey.com or Open Source solutions, like Joomla! with its 
enormous amounts of extensions. Joomla! has a front-end and administrator level 
back-end that is easy to use, with no need for HTML-coding, Perl or CGI-scripting for 
end-users. It is based on MySQL databases, and many ISPs have preinstalled Joomla! 
at their Web hotels. 
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Web versus postal questionnaires 
In a randomised comparison of Web versus mailed questionnaires Ritter et al.,[118] 
studied 397 volunteers randomly assigned to fill in questionnaires online or via paper-
and-pencil versions. With this apparently stronger RCT design, they found that out of 
16 instruments, none showed statistically significant differences; Web-based test-
retest reliability was high, and Web questionnaires required fewer follow-ups to 
achieve a slightly (non-significant) higher completion rate compared to mailed 
questionnaires. From my point of view, the ease of constructing Web forms and 
applications will hopefully lead to an increase in Web-based research. 
Anonymity 
We used no cookie technology, no IP-address tracing or other efforts to identify the 
respondents in order to secure privacy. The survey data were safely hosted at UNI•C, 
The Danish IT Centre for Education and Research. 
5.2.2 Limitations 
Representativity 
One of the limitations of Study II was its selection bias- whether our target 
population was underrepresented on the Web. The women in our Web study were 
younger and had more UI than in the EPINCONT study, the main finding in Paper II, 
affecting the external validity. UI is a condition that increases with age, and in our 
study the number of respondents decreases with increasing age. This selection bias is 
of importance in discussing our findings in Paper III. 
However, this finding may also contrast the ideas of social desirability bias, 
where respondents might want to present themselves as “better” than they are. In our 
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study it could have been that the respondents were be more open/frank about their UI 
than in the EPINCONT study. 
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5.3 Study II (Paper III) 
5.3.1 Strengths  
Correlation strategy 
One strength of Paper III might be the strategy to use correlation to assess the 
relationship between the ICIQ-UI and the ISI, and then weighted Kappa to assess the 
degree of agreement. Touvier et al.,[119] commented that agreement for continuous 
variables are best quantified by the ICC, whereas Kappas are best used for categorical 
variables. 
Bland & Altman argued against the use of correlations when comparing two 
measurements.[120] They argued that r measured the strength of a relationship between 
two variables, not the agreement between them, and that a change in scale of 
measurement did not affect the correlation, but certainly affected the agreement. 
Further, correlation depended on the range of the true quantity in the sample. If this 
was wide, the correlation would be greater than if it was narrow. Also, the authors 
stated that significance testing was irrelevant to the question of agreement. Finally, 
data that seemed to be in poor agreement could produce quite high correlations. 
Bearing these cautions in mind, it seemed scientifically acceptable to use correlation 
to check for a relationship between the ICIQ-UI SF and the ISI. 
In short, since correlation is different from agreement, Bland & Altman 
recommended the use of the Bland-Altman plot when comparing e.g. two 
instruments,[120]  for example for urodynamic testing. We were not able to use the 
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Bland-Altman plot, introduced in the Lancet in 1986,[120] since we were not measuring 
the same scale with two different instruments, and we measured on two different 
scales, although both measured severity. This is actually a substantial problem with all 
the different scales that have been developed for assessing UI, and one of the 
challenges the ICI now has decided to resolve by suggesting that only the ICIQ-UI 
modular scales should be used. But this was not the case in our study. We therefore 
had to use Kappa statistics, and used the Vassar Stats weighted Kappa statistics 
module[113] to enter the 4x4 contingency tables produced by SPSS. 
Kappa discussion 
Major criticism towards the use of weighted Kappa statistics was early formulated by 
Malcolm Maclure and Walter C. Willett in the American Journal of Epidemiology, 
focusing on the misinterpretation and misclassification of the Kappa statistics.[121] 
They claimed that Kappa was originally proposed to be a measure of agreement 
between two observers classifying subjects into two nominal categories. The problem 
arose when Kappa was applied to multicategory classifications, and used not only to 
assess reproducibility, but also validity. The authors pointed out that for continuous 
data grouped into ordinal categories for the mere convenience of the researcher, 
Kappa would be so arbitrary that it would be virtually meaningless. For naturally 
ordinal data, they claimed that the intraclass correlation coefficient (ICC) was 
superior to Kappa. And, for polytomous nominal data, the use of several Kappas for 
different combinations of dichotomies might be more informative than an overall 
Kappa for the polytomy. Finally, when assessing the validity, the authors pointed to 
better alternatives than Kappa, e.g. sensitivity, specificity, or positive and negative 
predictive values for nominal data, or the mean and standard deviation of a new 
  65 
measurement and the valid reference measurement, or the product-moment 
(interclass) correlation coefficient (ICC). 
Although weighted Kappa was developed to address the limitations of 
unweighted Kappa values, it has its own potential weakness as it allows weights to be 
arbitrary in relative magnitude, which means the magnitude of weighted Kappa may 
be arbitrary. To avoid this arbitrariness, they suggested that standard weights should 
be used. It turned ought, however, that a logical choice of standard weights in fact 
converted weighted Kappa equivalent to the intraclass coefficient.[121] 
However, Altman seemed to have no objections to the use of weighted Kappa 
in his well-known textbook ”Practical Statistics for Medical Research,”[122] where 
Altman points out that where the categories are ordered, as is often the case, it may be 
preferable to give different weights to disagreements according to the magnitude of 
the discrepancy. 
Weighted Kappa seems to be the right type of approach for our data, and I 
consider our strategy to use weighted Kappa to assess the agreement a correct one 
methodologically, due to two issues: 
• Both the ISI and ICIQ-UI SF are ordinal scales 
• Weighted Kappa is equivalent to the intraclass correlation 
In our study, we plotted four levels of the ISI against the ICIQ-UI SF total sum-score 
with and without the HRQoL dimension. The association between the ISI and ICIQ-
UI SF scores was investigated by Spearman’s rank correlation coefficient (rho), and 
the agreement was assessed by means of weighted Kappa. 
Other methods for developing severity grades (Rasch analysis) 
Handa and Massof pointed out that psychometric instruments may not necessarily 
have interval characteristics.[123] For example, numerical values like ”zero” or ”null” 
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may mean different things to researchers and patients. Secondly, the distance between 
score 0 to 50 and 50 to 100 may be perceived differently. Thirdly, summed scores 
may not be meaningful, and change in a summed score may be difficult to interpret. 
As an example, they wanted to test the hypothesis that incontinence-related 
disability is a variable that the grade A questionnaire IIQ with its 30 items would be 
able to measure. They used Rasch analysis,[124] a technique applying logistic 
regression analysis based on two mathematical assumptions. Firstly, the response 
given to any item by each respondent is a function of that individual’s disability level, 
and secondly, to the inherent difficulty of that item. The thinking behind this 
procedure is that a woman with slight SUI would only report difficulties performing 
the most strenuous tasks like jumping on a trampoline. By using WINSTEPS[125] they 
were able to iteratively estimate a scale for the IIQ, thereby demonstrating the spacing 
and hierarchical ordering of the 30 items comprising this score. After this initial 
phase, a goodness-of-fit analysis and separation-reliability analysis was performed. 
Further details of this are described in their paper.[124] 
By using the Rasch analysis, the researchers were able to rank and define 
interval characteristics of the IIQ along a continuum, permitting meaningful 
comparisons of change, e.g. before and after surgery. Examples of other scored 
questionnaires that have undergone Rasch analysis are well-known scales like the SF-
36 and Beck Depression Inventory. 
Albeit Handa and Massof’s study being underpowered (n=27), this validation 
method is interesting and feasible for questionnaires with many items. However, the 
ISI has two items and the ICIQ-UI SF has three scored items, and I question whether 
it is necessary for these scored questionnaires to be submitted to Rasch analysis, 
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having few items, and the fact that the first two items of both assess frequency and 
volume for both instruments. 
5.3.2 Limitations 
The concealment procedure 
Another weakness with Study II was that our concealment procedure reduced the 
total number of respondents from 1,812 respondents to 343 (19%), namely the 
responses from women with UI. This inadvertently led to loss of power, especially 
when we were defining the ”very severe” category, since we randomly split the UI 
sample into two halves to create samples for developing and validating the scaling of 
the ICIQ-UI SF. 
Skewed target population age 
Also, there was a skewed age distribution, our Internet population being younger than 
in most other epidemiological samples. Consequently, the severity categories we 
identified would probably not be valid for an elderly population. A study with a 
higher number of participants is necessary to clarify the ICIQ-UI SF levels for very 
severe incontinence, since our study had limited statistical power in the category 
“very severe,” thus affecting the external validity of our findings. 
Power calculations 
We did not perform any a priori power calculation, and this is a weakness with Study 
II, as it was for Study I. We did not know the prevalence of UI in a Web-recruited 
population a priori, although we could have assumed it to be the same as in the 
EPINCONT study, 25%. For the sake of statistical power more women should have 
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been included, since there were 2 women in the development sample (n=171) and 5 
women in the validation sample (n=172) belonging to the “very severe” category. 
We should have performed a power calculation to determine the appropriate 
sample size. We recruited 1,812 respondents, and 343 of these (19%) had UI and were 
branched to the UI-part of the study. By data splitting into two samples of 171 and 
172 respondents, even more power was lost. 
According to a posting at the MedStat discussion forum, power calculations 
for weighted Kappas cannot be done.7 Instead, we would have to use a confidence 
interval approach where we model the inputs in the contingency tables, also catering 
for a skewed distribution. We could have used Vassar Stats[113] for this purpose. For 
example, we could use the same skewness or distribution of UI severity as we found 
for the ICIQ-UI SF with the QoL-item in the development sample as in Table II in 
Paper III: 39% slight (63 of 163 women), 54% moderate, 6% severe and 1% very 
severe UI, and for the ISI the distribution would be 32% mild, 56% moderate, 10% 
severe and 2% very severe UI. Given that we would consider a 95% CI for Kappa 
with quadratic weighting to be no wider than 0.20, and not 0.62 (0.30 to 0.92) as in 
Table II of Paper III, we would have to enter the different scenarios into Lowry’s 
web calculator until we achieved an appropriate 95% CI.[113] 
To calculate the number of persons in each table cell for a sample size of 500, 
this is done as follows:  
(sample size · row percentage) · (cell#/row sum) = (500 · 0.39) · (38/63) = 118  
and so forth. If our validation sample size were e.g. set to 500, given the same 
distribution as in Table II, the result would be as follows: 
                                                 
7 http://groups.google.com/group/MedStats/browse_thread/thread/775b3aaea60cf292 
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These calculations show that the Kappa with quadratic weighting is 0.60, and 
the width of the 95% CI is 0.36 (0.42 to 0.78). In order to have a development sample 
of 500, using the same results as in our study, we would need 1000 women with UI. 
We found that 19% of our web respondents had UI, and would need a total sample of 
1000/0.19 = 5,263 women. Still, we only have 5 women in the “very severe” category 
of both the ICIQ-UI SF and the ISI. 
Similarly, if we recruit twice the number of women, 10,526, we would have 10 
women in the “very severe” category of both tests, unweighted Kappa (95% CI) 
would be 0.39 (0.34 to 0.44), while Kappa with quadratic weighting (95% CI) would 
be 0.60 (0.47 to 0.73), meaning that the width of the 95% CI is 0.20.  
By including 3,000/0.19 = 15,789 women, our validation sample would 
consist of 1,500 women, with 15 women in the “very severe” category. The 
unweighted Kappa (95% CI) would be 0.39 (0.35 to 0.43), and the Kappa with 
quadratic weighting (95% CI) would be 0.60 (0.50 to 0.70). We would then have 
achieved our aim of a 95% CI no wider than 0.20.  
However, if we aim at having 50 women in the “very severe” category, we 
would need to recruit 10,000/0,19 = 52,631 women. The Kappa with quadratic 
weighting (95% CI) would then be 0.60 (0.54 to 0.66). 
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6 Discussion of results 
6.1 Paper I 
Will this paper tell us how many women may proceed directly to surgery for their 
GSI without preoperative UDI? 
Given a cut-off level set to 3 for the DIS, the LR+ is 11.7, which tells us that it is an 
”excellent” test. These 56 women may proceed directly to surgery as the false positive 
rate, (1-specificity), is only 3% (1-0.97). This is not the same as a failure rate of 3%, 
probably due to “occult” DI (now termed DO) as termed by Kauppila et al.[101] The 
clinical challenge is which false positive rate is acceptable. Another way of thinking is 
that these 56 women would be the ones needing preoperative UDI. 
The ROC 
Simplifying preoperative assessments for patients with UI has been a challenge for a 
long time. For busy clinicians, valid and reliable assessment schemes are of great 
interest, especially if they can replace invasive examinations like urodynamic 
examinations. The NICE have already proposed that UDIs are not a mandatory 
procedure before starting many of the treatment options, especially the conservative, 
non-surgical options.[30] 
Using the ROC-curve gives a graphical view of the data. The point that is 
closest to the upper left (North-Western corner)[108] is the point that gives the most 
optimal cut-off levels. But, we also have to take into account the risk of the treatment. 
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Technically, the ROC-curve is just a plot of the true positive rates against the false 
positive rates, which is the same as plotting the sensitivity against the (1-specificity) 
rate. 
The ROC curve 
Using the ROC-curve to display the different cut off values is also a methodological 
strength, allowing us to discuss the optimal, theoretical cut-off point, versus the 
clinical challenges of surgical and conservative treatments. In addition, this is 
regarded as a far better approach than just looking at sensitivity, specificity, PPV, 
NPV and accuracy. By using the ROC-curve, it is easy to discuss the optimal cut-off 
level, as it is usually the point closest to the upper left corner of the diagram. Also, the 
closer that point is to that corner, the greater the test is accuracy of the test is, as 
measured by the area under the curve (AUC). 
SpPins and SnNouts 
In Sackett et al.’s book on practising and teaching EBM,[126] two acronyms may be 
helpful: SpPins and SnNouts. In our discussion in Paper I, we actually mixed around 
these concepts. We wrote: ”Using a rule in sensitivity at 0.80, we register this at a DIS 
cut-off point at 7. A rule out level for the specificity at 0.80 would yield a cut-off level 
around 5.” According to Sackett et al., this should have been formulated as SpPins 
and SnNouts. The sentence should instead have been phrased like this: ” For a cut-off 
point set to 5 for the DIS, a positive test rules in the patient as not having GSI. For a 
cut-off point for the DIS set to 7, a negative test rules out the patients as having GSI. 
In general, in secondary care setting, we need SpPins, while we need SnNouts in 
primary care settings. 
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Likelihood ratios – an even better approach to understanding tests? 
Likelihood ratios may be calculated as:[108, 126] 
LR+ = sensitivity/(1-specificity) 
LR- = (1-sensitivity)/specificity 
The likelihood ratios indicate by how much a given diagnostic test result would raise 
or lower the posttest probability of the target disorder. A likelihood ratio of 1.0 means 
the posttest probability is the exactly the same as the pretest probability, and thus a 
useless test. The closer a test is to 1, the less useful it is.[126] As a rough guide, I have 
set up a table on the interpretation suggested by central textbooks on clinical 
epidemiology and EBM:[108, 126, 127]  
 
Table 3.2.1 Interpreting likelihood ratios 
Change in post-test probability English Norwegian LR+ LR- 
Large Excellent Utmerket ≥10 ≤0.1 
Moderate Good God 5-10 0.1-0.2 
Small, but sometimes important Fair Middels god 2-5 0.2-0.5 
Small, and rarely important Poor Dårlig 1-2 0.5-1 
 
Bearing this in mind, so-called excellent tests would be the ones with either an LR+ 
≥10 or an LR- ≤0.1, while tests with LR+ between 1 and 2 or LR- between 0.5 and 1 
are not useful tests, as they provide almost no change of the post-test probability. In 
this way, I have chosen terms characterise tests as excellent, good, fair and poor. 
JAMA has for many years published a series of papers “The rational clinical 
exam,” where the authors calculate pooled LRs for symptoms, signs and 
investigations. Two relevant examples are relevant for this thesis: “What type of UI 
does this woman have?”[128] and “Does this woman have an acute uncomplicated 
UTI?”[129] Both of these papers demonstrate how it is possible to combine pooled LRs 
for symptoms, signs and findings in an elegant manner.  I would have chosen to 
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present the likelihood ratios as well if we should write this paper today. The data in 
the paper have been recalculated and presented as such in the HTA-report.[130] In 
Table 2, I present how I would have chosen to present the data today. 
Table 2. Data from Paper I recalculated.  
DIS N= Sensitivity (%) Specificity (%) LR+ LR- 
DIS 0-1 16 10 99 10,0 0,9 
DIS 0-2 39 25 99 25,0 0,8 
DIS 0-3 56 35 97 11,7 0,7 
DIS 0-4 78 45 90 4,5 0,6 
DIS 0-5 112 60 77 2,6 0,5 
DIS 0-6 140 69 59 1,7 0,5 
DIS 0-7 159 77 52 1,6 0,4 
DIS 0-8 183 85 38 1,4 0,4 
DIS 0-9 204 92 26 1,2 0,3 
DIS 0-10 219 94 13z 1,1 0,5 
 
The recommended manner of interpreting these LRs is that an excellent test has an 
LR+ ≥10, a good test 5-10, while a fair test lies in the range of 2-5. Tests between 1-2 
are poor, and of no use, as they hardly change the post-test probability. Consequently, 
this approach shows that the DIS is a poor test if the cut-off level is set to 7. Even so, 
an LR+ = 2.6 for a cut-off value set to 5 for the DIS only makes it a “fair” test, 
defining 112 women (44.8%) as having GSI. 
Fagan’s nomogram 
Fagan’s nomogram[131] is another way of modelling diagnostic reasoning. Most often, 
working as a GP means handling patients with mostly low-prevalent issues. UI, on the 
other hand, is actually a high-prevalent condition in general practice (20-25%). This 
means that positive findings are actually more often true positive than false positive 
findings, as is not the case in low-prevalent conditions. This means that we should be 
able to safely diagnose and initiate conservative treatment in general practice. 
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Fagan’s nomogram also enables us to model the sequencing of diagnostic 
tests. Ideally, these sequential tests should be statistically independent tests.  The 
principle is that that post-test probability of test number one is the pretest probability 
of test number two, and so forth. In this way, it is possible to increase the post-test 
probability of a poor or fair to a threshold before e.g. more invasive and potentially 
harmful treatment. For example, if the pre-test probability of detrusor instability is 
10%, and a woman scores DIS = 5, the post-test probability is found by drawing a line 
through 5% and LR+ = 2.6, yielding a post-test probability of approximately 25%, 
thereby being a fair test. Similarly, for a woman who scores DIS = 7 (LR+ = 1.6), the 
post-test probability is about 12%. These figures can be determined more precisely by 
converting from probabilities to odds ratios and back again, as I show in my Web 
presentation at http://www.uib.no/isf/people/atle/diagnosis/. 
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There are many different approaches to presenting findings from diagnostic 
studies, each of them shedding a different light over the presentation of the results: A 
systematic review and evaluation of methods of assessing urinary incontinence 
advocates the use of diagnostic odds ratios, DORs.[117] 
External validity 
According to Professor David Sackett, external validity is more an issue of 
particularising to the individual, than of generalising to all.[108] 
The outpatient setting of Study I reduces the external validity of the findings 
in primary health care, and because of this, the prevalence is very high, 45%. This 
limits the particularising of the findings to primary health care settings. Hunskaar et 
al. reported in a paper published in 1996[132] that the GP’s gatekeeper function results 
in specialists having a higher prevalence of condition than primary care physicians. 
The consequence of this is that findings at one level of care are not necessarily valid 
at the other level. 
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6.2 Paper II 
Which direction does social desirability bias take us in Study II? 
Paper II, Fig. 1 shows that the WEB-EPI UI respondents were younger than the 
EPINCONT respondents, while Fig. 2 shows that they were more incontinent as well. 
According to the epidemiology section of the 3rd ICI report[24] (p. 280), the prevalence 
of UI seems to vary over a range of 20%-30% in young women, 30%-40% around 
menopause and thereafter increasing to 30%-50% in the elderly female population.  
Albeit this, the prevalence of severe UI seems to range between 6% and 10%. 
Criticism against this wide variation in prevalence estimates for UI was raised 
by Fultz and Herzog,[133] who claimed that this was caused by many different biases 
where coverage and sampling bias, nonresponse bias, measurement bias and social 
desirability bias were the most important. 
Our major finding was that the Web users we attracted were younger and had 
more severe incontinence than in the EPINCONT study. It is not surprising that they 
were younger, as UI increases with increasing age; but the fact that they had more 
severe UI is surprising. This could be interpreted in two ways. UI is by many 
considered to be a taboo theme, making it easier for women to state the severity of 
their incontinence online than in real life, or that the self-selection bias introduced by 
convenience sampling led to the recruitment of women with more severe UI. 
 78 
External validity 
The findings in Study II presented in this paper show that the age bias greatly affects 
the external validity; the fact that we attracted a younger population with more severe 
UI than the postal method it was compared with. 
Mick Couper discusses the concept of “non-observation,” sampling, coverage 
and non-response as errors of non-observation. In Paper II, we had no intention to 
check for non-observation, or the different aspects of it as Couper states: [88]  
“While the Internet offers a lot of promise for eHealth research, it also suffers 
some notable limitations. Key among these are the challenge of drawing 
representative samples of the population, of dealing with the issue of people 
without Internet access, and of minimizing the potential for nonresponse bias in 
Web surveys. On the other hand, the cost of Web surveys relative to alternative 
modes, the speed with which they can be conducted, and the ability to combine 
the power of computerised survey instruments with the advantages of self-
administration, make this a valuable research tool under certain conditions.” 
Although the Web-based sample we recruited was age-biased, thus affecting the 
external validity of our findings, this does not imply that Web-based methods are not 
useful for epidemiological studies. Rather, emphasis should be on using the Web as 
one of several modes of recruiting participants for studies. 
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6.3 Paper III 
First study to grade the ICI recommended PRO-questionnaire: The ICIQ-UI SF 
The ICIQ-UI SF has been translated to 38 languages,[25] validated in many studies, 
and is now the recommended initial assessment tool with validated responsiveness 
making it useful as an outcome measure as well. Hopefully this will make cross-
comparisons between different studies more feasible. This study is the first to propose 
a scale for the ICIQ-UI-SF. As described in Paper III, we were thus able to propose a 
4-level severity scale for the ICIQ-UI SF, with and without the HRQoL-dimension: 
  
ICIQ-UI SF With the QoL item Without the QoL item 
Slight 1-5 1-3 
Moderate 6-12 4-5 
Severe 13-18 6-9 
Very severe 19-21 10-11 
HRQoL vs. severity vs. bother 
The QoL-concepts of bother and severity need some clarification. It is important to 
remember that severity says something about the frequency and amount of urinary 
leakage, while bother is the woman’s perception of how UI affects her life. Severity 
was thus a seemingly objective measure, while bother is a subjective measure. 
According to the current ICS definition, UI is defined as ”any leakage, ” and the 
”bother” item was left out of the definition in 2001. This may be problematic for the 
ICIQ-UI SF, which has built in the bother scale as a VAS. In Paper III we have 
challenged this, and calculated the correlation between the ISI and the ICIQ-UI SF 
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with and without the QoL dimension. We found that the correlation was greater 
without the QoL dimension. 
Haltbakk et al. [134] found that patients with prostatic problems were more 
bothered by irritative than obstructive symptoms. The authors argue that although 
single-item QoL-scores show a satisfactory responsiveness to change for all treatment 
methods, and more complex measures show diverging results, they question whether 
one-item instruments are suitable for research purposes. As QoL often encompasses 
various aspects like sexual function and quality of sleep, multidimensional 
instruments would be needed to assess these issues. 
If we take a closer look at Fig. 1 in Espuña-Pons and Puig-Clota’s paper,[135] 
we see that the total score is given for the ICIQ-UI SF for women without UI during 
sexual intercourse is 12.1 (moderate), while it is 14.1 (severe) for women  with coital 
UI. The authors make a point of the fact that it seems like the “bother”-item 
contributes most to this difference. 
However, if item 3 is subtracted, the ICIQ-UI SF scores are 6.2 and 7.4, 
respectively, thus making both of them “moderate” according to our grading without 
the QoL-item. What are the consequences of this finding? I am tempted to think that 
the ICIQ-UI SF actually mixes/blends the “objective” severity grading with the 
“subjective” bother VAS-item represented as a VAS-score. Both dimensions are 
important, but putting them into one sum score seems to create some problems. It will 
be interesting to see how future researchers will cope with this issue. 
External validity 
In Paper III we demonstrated a high correlation between the ISI and the ICIQ-UI SF, 
and were able to propose a four-level scale for the ICIQ-UI SF. This finding needs 
reassessment in future studies, as our study had limited power in the “very severe” 
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group, and limitations due to the age bias found in Paper II. However, the Web-based 
method functioned well for validating the ICIQ-UI SF against the ISI. 
 82 
 
 
 
 
  83 
7 Conclusions and implications 
7.1 Conclusions 
7.1.1 Study I (Paper I) 
In conclusion, findings from Study I in this thesis suggest that lowering the cut-off 
value for the DIS to 5 is necessary when the choice of treatment is surgery, since 
fewer patients with false positive findings may be tolerated because they may have 
other types of UI, compared to non-surgical and harmless treatment. On the other 
side, treating patients with false positive diagnostic findings by increasing the cut-off 
value to 7 for harmless treatments like pelvic floor exercises may be deemed 
acceptable. Using scored diagnostic questionnaires requires balancing test 
characteristics like sensitivity and specificity or likelihood ratios on one side, and 
setting, purpose and consequence on the other side. This is essential when considering 
surgical versus conservative treatment options for UI. 
7.1.2 Study II (Paper II and III) 
Web-based recruitment for epidemiological studies of conditions functioned well, 
technologically. But for conditions where the prevalence rises with age, it may be 
problematic, while it may be useful for studying conditions that affect the younger 
part of the population. We found that we recruited a younger population with more 
severe UI in the WEB-EPI UI study than in the EPINCONT study. Using the World 
Wide Web for validating questionnaires was feasible, and probably all types of self-
administered questionnaires may be possible to deploy. 
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We found that the ICIQ-UI SF may be graded into the following four severity 
grades: slight (1-5), moderate (6-12), severe (13-18), and very severe (19-21). 
Without the QoL-item, the grades were slight (1-3), moderate (4-5), severe (6-9), and 
very severe (10-11). 
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7.2 Implications for research 
This PhD-thesis is based on two studies, with data collected from 1988 to 1992 for 
Study I, and in 2002 for Study II. As described in the acknowledgement section, my 
research has been done as combined work as researcher and GP in several phases, 
Study I in 1993-1996, and Study II from 2001-2003, and after moving to Oslo, from 
2006 and onwards. Often, PhD-theses are submitted when the first papers are 
accepted and the third paper is submitted, long before the papers are cited. I therefore 
thought it would be interesting and relevant to see the implications of my own 
research, as time has gone in the finalising of this PhD. By using Scholar Google and 
ISI Web of Knowledge,8 I found that Paper I is cited by ten papers,[117, 128, 136-143] 
Paper II by one,[119] and that Paper III is cited by two papers.[135, 144] 
7.2.1 Citations: Paper I 
1. Amundsen et al. (1999): A criterion validity study 
The first paper to cite Paper I was a criterion validity study by Amundsen et al.[136] 
published in 1999, validating whether urinary symptoms correlate with video 
urodynamic findings. This study was not designed to establish a validated 
questionnaire for urinary incontinence. 
The authors claimed that UI is a common problem affecting up to 40% of the 
female population, a much higher prevalence estimate than the 20-25% large 
descriptive epidemiological studies like the EPINCONT show. The authors argue that 
                                                 
8 Search date: 19 May 2010 
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it is well known that symptoms of urgency incontinence frequently are not easy to 
demonstrate by urodynamic investigations, and they were unable to identify by the 
questionnaire which patients would have detrusor instability, and to confirm this with 
video urodynamics. The authors found instead that patients with urgency 
incontinence, urgency and frequency rarely had DI. 
Citing Paper I, the authors found that even using a questionnaire designed to 
screen for urge symptoms (the DIS), stress incontinence was not accurately predicted 
and the rate of false-positive results for detrusor instability was high. The authors 
conclude that in their study, only questions about leaking during activity were helpful 
in differentiating the aetiology of incontinence, and no questions were helpful in 
predicting abnormalities other than stress incontinence. 
2. Gray et al. (2001): A prediction model for motor UUI 
In 2001, Gray et al.[137] developed a prediction model for motor urge urinary 
incontinence to improve the diagnostic strength of a scored questionnaire in detecting 
urgency or mixed UI. The study researchers used logistic regression analysis to 
develop the prediction model, based on urodynamic findings and clinical diagnosis in 
148 patients. This model was consistent with previous findings, showing that the 
medical history predicts SUI better than it predicts UUI and MUI. 
Paper I is described as part of the authors’ non-systematic review of 
relevant literature in their section on “Related Literature,” and the authors argued that 
we observed that a diagnostic instrument must have a high specificity when surgical 
treatment, with its risk of complications, was used to manage UI. Because the DIS at a 
cut-off level of 7 yielded a specificity of only 52%, they concluded that it lacked 
sufficient predictive power to alter a decision to perform surgery in women with UI. 
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Pursuing this argument, they should have commented that we also studied the 
consequences of lowering the DIS to 5, turning the DIS into a SpPin. 
3. Graham et al. (2002): Non-systematic review 
In an unsystematic review of the literature from 2002, Graham et al.[138] cites Paper I 
as a validity study of the Detrusor Instability Score (DIS), quantifying the extent of DI 
symptoms to discriminate stress from urge as the cause of incontinence. 
They describe the wording of several items to be clumsy, possibly suffering 
from translation from Finnish, but nonetheless that it had been validated for use in an 
English language population. The DIS has been compared with urodynamic findings 
in two studies by the creators of the score[101, 102] and in Paper I, and in both studies; a 
low DIS-score (0-5) had reasonable predictive value for the absence of a hypertonic 
bladder or detrusor instability. Although sensitivity and specificity were considered 
marginal, the DIS has a positive predictive value of 0.82 in an outpatient setting for 
determining which patients would not demonstrate detrusor instability on urodynamic 
evaluation. The authors did not present Kujansuu’s validation study.[102] 
4. Sveen et al. (2004): Quality of life study after stroke 
In 2004, a HRQoL-study after stroke was published by Sveen et al.,[139] where UI was 
recorded by a scale for scoring the urological history as in Paper I, incorporating the 
DIS, and administered by a specially trained nurse. The score of the DIS is not 
presented. The authors concluded that demographic variables and selected impairment 
tests measuring UI and aphasia did not contribute significantly to explaining well-
being after stroke. More important factors were place of residence and leisure 
activities. 
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5. Bradley et al. (2005): Development and validation of a new questionnaire 
As part of developing and validating a new scored questionnaire for UI, the QUID, 
Bradley et al. [140] refer to the original study by Kauppila[101] and Paper I, but not to 
Kujansuu’s validation study.[102] 
Apart from describing the test characteristics, their main conclusion was that 
in the 250 Norwegian urogynaecology patients studied in Paper I, the diagnoses of 
the detrusor instability scores were 66% accurate for stress urinary incontinence and 
68% accurate for urge incontinence, and that an English version of the detrusor 
instability score had not been tested to their knowledge, and reliability characteristics 
of the survey were unknown. The authors incorrectly cite Paper I, as we did not find 
an accuracy of 68% for urge incontinence. What we showed was that the accuracy for 
DIS 0-5 was 66% and for DIS 0-7 it was 68%. 
6. Brown et al. (2006): A criterion validity study 
In 2006, Brown et al.[141] conducted a criterion validity study of the 3IQ questionnaire, 
a simple, quick, and non-invasive test with acceptable accuracy for classifying urge 
and stress incontinence among middle-aged women, with an extended 
urogynaecological evaluation as the gold standard. They found that the LR+ and LR- 
with 95% confidence intervals for the 3IQ compared with the extended evaluation 
were 3.29 (2.39-4.51) and 0.32 (0.24-0.43) for UUI, and 2.13 (1.71-2.66) and 0.24 
(0.16-0.35) for SUI, respectively. They concluded that their findings should be 
replicated in other primary care clinical settings. In addition, they claimed that clinical 
outcomes should be assessed in a trial comparing treatments based on the 3IQ and the 
extended evaluation. 
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Paper I is one of 7 papers described in Table 5 as one of the published studies 
evaluating the accuracy of questionnaires to classify type of urinary incontinence in 
women, and as such is a validation study. 
7. Gustafsson et al. (2006): A 3-year cohort study after hysterectomy 
Gustafsson et al.[142] published a paper in 2006 using the DIS in a three-year 
observational cohort study on UI after hysterectomy. Paper I was cited as a validation 
study of the DIS. In this study, the DIS was used preoperatively, postoperatively, after 
one and three years. They found that total hysterectomy was not associated with 
increase in UUI or SUI. 
8 and 9. Martin et al. (2006): A Cochrane Review and a systematic review 
Martin et al. [117] performed a Cochrane review and published a synopsis of  this in the 
N&U.[143] Among the identified 6,009 studies originally found in the literature, 1,479 
were duplicates. After reading all the 4,620 abstracts, 490 studies were found to be 
potentially relevant. After reading the full papers, only 121 studies met the inclusion 
criteria of the review, and Study I was one of the studies that qualified for inclusion. 
Being the only validation study included, data could of course not be pooled. 
10. Holroyd-Leduc et al. (2008): The Rational Clinical Examination 
The JAMA-series on “The Rational Clinical Examination” published in 2008 “What 
type of urinary incontinence does this woman have?”[128] and used findings from 
Paper I in Table 3; Questionnaires used to diagnose urge and stress incontinence. 
With a cut-off set to 5, the DIS yielded an LR+ and LR- of 2.6 and 0.52, respectively. 
This paper is actually a clinical scenario to be solved by data from a systematic review 
of the literature accompanied by a meta-analysis yielding pooled likelihood ratios. 
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In this paper, the authors argue that in light of the controversy of urodynamics 
in diagnosing urinary incontinence, they chose to include studies that used 
urodynamics, expert opinion or both as the gold standard. In order to check whether 
including expert opinion as part of the gold standard had any effect, they performed a 
sensitivity analysis by removing altogether 6 of the studies (including Paper I) from 
the meta-analysis, finding that this did not alter the main findings. The authors thus 
concluded that including these 6 studies using the combined “expert opinion with 
UDI” did not result in biased conclusions. 
7.2.2 Citations: Paper II 
1. Touvier et al.[119] A comparison between Web-based and paper versions of a self-
administered questionnaire 
In this comparison of a Web-based and paper version of a self-administered 
questionnaire, the NutriNet-Santé anthropometric questionnaire, data concerning 17 
questions divided into subquestions (55 variables in all) dealing with height, weight, 
hip and waist circumferences, weight history, restrictive diet and weight self-
perception were collected. Both versions of the questionnaire were filled in by 147 
volunteers (paper version first, N = 76, or Web-based version first, N = 71). 
Agreement was assessed by intraclass correlation coefficients (ICCs) for 
continuous variables and Kappas for categorical variables. Agreement between the 
two versions was high. ICCs ranged from 0.86 to 1.00. Kappas ranged from 0.69 to 
1.00 for comparable variables. A total of 82 data entry mistakes (1.5% of total 
entries), 60 missing values (1.1%), 57 inconsistent values (1.1%) and 3 abnormal 
values (0.1%) were counted in the paper version (non-existent in the Web-based 
version due to integrated controls). The Web-based version was preferred by 92.2% of 
users. 
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In conclusion, the quality of information provided by the Web-based 
anthropometric questionnaire used in the NutriNet-Santé Study was equal to, or better 
than, that of the paper version, with substantial logistic and cost advantages. 
A key question in large-scale internet-based studies concerns their capacity to 
reach a sufficiently broad and diversified population. Although use of computer-based 
questionnaires may exclude segments of the population without access to, or the 
capacity to use, computers (notably the elderly [as in Paper I]), Internet access is 
constantly increasing throughout the World. 
7.2.3 Citations: Paper III 
Paper III has at the time of writing (July 2010) been cited twice, by Espuña-Pons[135] 
and by Novara et al.[144] The four-level scale we developed for the ICIQ-UI SF will 
probably be of interest for researchers of future studies using the ICIQ-UI SF. Still, 
we think it may be in need of reliability testing by other researchers and in different 
settings like first and secondary care, and for different kinds of diagnostic procedures 
and treatments. Although authors publish the ICIQ-UI SF total score and its three 
items, the four-level grading might be more meaningful. As stated in 4.1.3, the ICIQ-
UI SF may be divided into the following four severity categories: slight (1-5), 
moderate (6-12), severe (13-18), and very severe (19-21). 
1. Espuña-Pons and Puig-Clota (2009): Cross-sectional study on sexual UI 
In a cross-sectional, epidemiological multicentre study on UI during sexual 
intercourse,[135] Espuña-Pons and Puig-Clota used the King’s Health Questionnaire 
(KHQ) and the Spanish version of the ICIQ-UI SF, and found a prevalence rate of 
29.4% in 1,292 sexually active women that had UI during sexual intercourse, and that 
these women not only had lower quality of life (higher UI-SF total score), but also 
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greater severity. In Figure 1 of this paper they cite the severity scaling we developed 
in Study II and published in Paper III. This figure shows the ICIQ-UI SF total, and 
also the frequency, quantity and impact items, and conclude that it is the impact item 
that contributes most to the ICIQ-UI SF total score for these women. They found that 
women with and without UI during sexual intercourse had an ICIQ-UI total score of 
14.1 (severe UI) and 12.1 (moderate UI), respectively. Of women with coital UI vs. 
not coital UI, more had SUI (38% vs. 28%) and fewer had UUI (17% vs. 27%) 
(P<0.001). Of women with SUI, 36% had coital UI, while only 20% of the women 
with UUI had coital UI. 
2. Novara et al. (2010): 44-month cohort study on radical cystectomy 
In a 44-month follow-up study of 113 patients who had undergone radical cystectomy 
(RC) for bladder cancer and were alive and disease-free,[144] the four-level scale 
devised in Paper III was used to assess the severity of UI. Novara et al. found that 20 
(18%) were continent (score 0), and that 32%, 35% and 15% had slight, moderate and 
severe UI according to the grading we developed as part of Study II. None had very 
severe UI. They also used other validated questionnaires to evaluate LUTS, UI and 
erectile function, and strongly recommended the use of validated questionnaires after 
surgery. 
As an example, they argued that despite the large number of papers in their 
research field, none hade ever used validated questionnaires to assess the LUTS 
function. And, by using previous criteria, like defining continent patients either not 
using pads/condoms, or in some case series those using a safety pad for occasional 
leakage. Using these two criteria, 69% and 91% were defined to be continent during 
daytime, while 25% and 85% were continent during night time. By applying the 
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Italian ICIQ-UI SF the found fewer to be continent, and judged this to be more 
realistic.  
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7.3 Possible implications for future research 
The ICI has suggested researchers and clinicians use the ICIQ-UI SF and from the 
other ICIQ modules for all research on UI; this might imply that the severity grading 
in Paper III might be a paper that could be useful in many future studies. Still, I think 
there might be other researchers that would be interested in challenging this grading 
of the ICIQ-UI SF.  
Also, many researchers might find the statement on page 368 in the chapter on 
“Initial Assessment of Urinary and Faecal Incontinence in Adult Male and Female 
Patients” of the 4th ICI controversial or even provoking.[26] The ICI state that the 
current Fourth Consultation represents a departure from the recommendation scheme 
of the previous reviews, and although questionnaires will still be graded A, B, or C, 
the recommendation is to preferably use questionnaires from the ICIQ modules. 
Should none of the modular questionnaires be appropriate for research or clinical 
purposes, this recommendation of the ICI is to use an earlier Grade A questionnaire, 
or if no suitable instrument exists, a Grade B or C questionnaire. 
Findings from the two studies in this thesis have suggested that there has been 
a need for research that explores the usefulness of simple methods for better 
assessment of UI. But, with the finalising of the ICIQ-modules, its translation into 38 
languages, and in light of the sound validation work that has been undertaken, it is 
high time that UI researchers acknowledge that no more questionnaires need to be 
developed in the future, as researchers would now have a common, complete platform 
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in the ICIQ-modules. Future research would then enable cross-comparisons and meta-
analyses. 
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 Appendixes 
Appendix 1 
The questionnaire used Study I. The DIS was embedded into this questionnaire 
(Paper I). 
 
Appendix 2 
The EPINCONT questionnaire which was embedded into the Web-based 
questionnaire used in Study II (Paper II and III). 
 
Appendix 3 
The ICIQ-UI SF questionnaire, which was embedded into the Web-based 
questionnaire used in Study II (Paper III). 
 
Appendix 4 
The Web-based questionnaire, which was used in Study II (Paper II and III). Logos, 
banners, Web pages and the interview published on the Web. 
 	  

